KR20010022632A - Process for Producing LH-RH Derivatives - Google Patents

Process for Producing LH-RH Derivatives Download PDF

Info

Publication number
KR20010022632A
KR20010022632A KR1020007001226A KR20007001226A KR20010022632A KR 20010022632 A KR20010022632 A KR 20010022632A KR 1020007001226 A KR1020007001226 A KR 1020007001226A KR 20007001226 A KR20007001226 A KR 20007001226A KR 20010022632 A KR20010022632 A KR 20010022632A
Authority
KR
South Korea
Prior art keywords
leu
ser
arg
pro
tyr
Prior art date
Application number
KR1020007001226A
Other languages
Korean (ko)
Inventor
가시모토가즈히사
나가노유미코
오하타아키코
Original Assignee
나카무라 도유
이토햄 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 나카무라 도유, 이토햄 가부시키가이샤 filed Critical 나카무라 도유
Priority claimed from PCT/JP1997/002705 external-priority patent/WO1999007874A1/en
Publication of KR20010022632A publication Critical patent/KR20010022632A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

본 발명은 하기 일반식(1)로 표시되는 펩티드 단편과, 하기 일반식(2)로 표시되는 펩티드 단편을 키모트립신 또는 키모트립신키모트립신의 존재하에서 반응시키는 것을 특징으로 하는, 일반식(3)으로 표시되는 LH-RH 유도체의 제조방법의 제공한다.The present invention is characterized by reacting the peptide fragment represented by the following general formula (1) and the peptide fragment represented by the following general formula (2) in the presence of chymotrypsin or chymotrypsin chymotrypsin. It provides a method for producing a LH-RH derivative represented by.

pGlu-His-Trp-OR1(1)pGlu-His-Trp-OR 1 (1)

H-Ser-Tyr-X-Leu-Arg-Pro-Y (2)H-Ser-Tyr-X-Leu-Arg-Pro-Y (2)

pGlu-His-Trp-Ser-Tyr-X-Leu-Arg-Pro-Y (3)pGlu-His-Trp-Ser-Tyr-X-Leu-Arg-Pro-Y (3)

상기 식에서,Where

R1은 저급 알킬을 나타내고,R1 represents lower alkyl,

X는 D-Leu, D-Ser(But), D-Trp, (2-나프틸)-D-Ala 등의 D-형 아미노산 및 Gly로 이루어진 군에서 선택된 아미노산을 나타내고,X represents an amino acid selected from the group consisting of D-type amino acids such as D-Leu, D-Ser (But), D-Trp, (2-naphthyl) -D-Ala and Gly,

Y는 Gly-NH2, Azgly(아자글리신)-NH2또는 NHR2(R2는 저급 알킬이다)을 나타낸다.Y represents Gly-NH 2 , Azgly (azaglycine) -NH 2 or NHR 2 (R 2 is lower alkyl).

라세미화 등의 부반응을 수반하지 않으므로 LH-RH 유도체의 분리, 정제가 용이하며, 또한 수율이 높고 미반응의 단편을 회수하여 재이용 가능하므로 공업적으로 매우 유용하다.Since it does not involve side reactions such as racemization and the like, the separation and purification of LH-RH derivatives is easy, and the yield is high, and since the unreacted fragments can be recovered and reused, it is very industrially useful.

Description

LH-RH 유도체의 제조방법{Process for Producing LH-RH Derivatives}Process for Producing LH-RH Derivatives

<110> ITOHAM FOODS INC.<110> ITOHAM FOODS INC.

<120> Process for Producing LH-RH Derivatives<120> Process for Producing LH-RH Derivatives

<130> FP0001/H&A/JP<130> FP0001 / H & A / JP

<160> 4<160> 4

<170> KOPATIN 1.5<170> KOPATIN 1.5

<210> 1<210> 1

<211> 10<211> 10

<212> PRT<212> PRT

<213> Artificial Sequence<213> Artificial Sequence

<220><220>

<223> Xaa denotes a pyroglutamic acid residue<223> Xaa denotes a pyroglutamic acid residue

<400> 1<400> 1

Xaa His Trp Ser Tyr Gly Leu Arg Pro GlyXaa His Trp Ser Tyr Gly Leu Arg Pro Gly

1 5 101 5 10

<210> 2<210> 2

<211> 4<211> 4

<212> PRT<212> PRT

<213> Artificial Sequence<213> Artificial Sequence

<220><220>

<223> Xaa of the amino acid number 2 denotes Arg(NO2), and Xaa of the a<223> Xaa of the amino acid number 2 denotes Arg (NO2), and Xaa of the a

mino acid number 4 denotes Azgly(azaglycin)-NH2mino acid number 4 denotes Azgly (azaglycin) -NH2

<400> 2<400> 2

Leu Xaa Pro XaaLeu Xaa Pro Xaa

<210> 3<210> 3

<211> 4<211> 4

<212> PRT<212> PRT

<213> Artificial Sequence<213> Artificial Sequence

<220><220>

<223> Xaa denotes Azgly-NH2<223> Xaa denotes Azgly-NH2

<400> 3<400> 3

Leu Arg Pro XaaLeu Arg Pro Xaa

<210> 4<210> 4

<211> 7<211> 7

<212> PRT<212> PRT

<213> Artificial Sequence<213> Artificial Sequence

<220><220>

<223> Peptide<223> Peptide

<400> 4<400> 4

Ser Tyr Gly Leu Arg Pro GlySer Tyr Gly Leu Arg Pro Gly

1 51 5

황체형성 호르몬(LH) 및 난소 자극 호르몬(FSH)은 시상하부에서 생성하는 황체형성 호르몬 방출 호르몬 LH-RH의 지배하에서 뇌하수체전엽으로부터 방출된다. LH-RH 및 그 유도체는 성선자극 호르몬 분비활성을 가지며 연속투여에 의하여 성선기능의 억제현상이 인정되므로, 예를 들어 자궁내막염, 중추성 사춘기 조발증, 불임증, 전립선암 등의 예방 및/또는 치료약으로서 응용되고 있다. 이미 의약품이 되어 있는 것으로는 부세레린(참조: 특공소 60-9519), 고세레린(참조: 특공소 61-13480), 류프로레린(참조: 특공소 53-14072), 나파레린(참조: 특공소 63-56238)이 있다.Progesterone (LH) and ovarian stimulating hormone (FSH) are released from the anterior pituitary gland under the control of the luteinizing hormone releasing hormone LH-RH, which is produced in the hypothalamus. Since LH-RH and its derivatives have gonadotropin-releasing activity and inhibition of gonadotropy is recognized by continuous administration, for example, prophylactic and / or therapeutic drugs such as endometritis, central puberty, infertility, and prostate cancer It is applied as. Drugs already available include Busererin (Ref. 60-9519), Gosererin (Ref. 61-13480), Ryuprorelin (Ref. 53-14072), Naparerin ( Reference: Commando 63-56238.

상기 LH-RH 및 그 유도체의 제조방법으로, 그 폴리펩티드에 대응하는 부분서열을 갖는 펩티드 단편을 액상법 또는 코팅법으로 형성하게 하고, 각 단편을 액상에서 다시 커플링시키는 액상합성법에 의한 화학합성법(참조: 특공소 56-47175, 특개소 49-117468, 특공소 57-29462, 특공소 57-25540, 특공소 63-17839, 특공소 63-45398, 특개소 48-40770, 특개소 50-88069, 특개소 49-41375, 특개소 49-41376, 특개소 48-99170, 특공소 52-20996, 특개소 49-35381, 특공소 52-8831, 특공소 57-61268, 특공소 53-14072, 특공소 57-26506, 특공소 60-22720, 특공소 61-13480, 특공평 3-71439)이 알려져 있다.In the method for producing the LH-RH and its derivatives, a chemical synthesis method by a liquid phase synthesis method in which a peptide fragment having a partial sequence corresponding to the polypeptide is formed by a liquid phase method or a coating method, and each fragment is coupled again in a liquid phase (see : Special Offices 56-47175, Special Offices 49-117468, Special Offices 57-29462, Special Offices 57-25540, Special Offices 63-17839, Special Offices 63-45398, Special Offices 48-40770, Special Offices 50-88069, Special Offices Point 49-41375, Point 49-41376, Point 48-99170, Point 52-20996, Point 49-35381, Point 52-8831, Point 57-61268, Point 53-14072, Point 57 -26506, Special Forces 60-22720, Special Forces 61-13480, and Special Engineers 3-71439.

그러나, 액상합성법으로는 펩티드의 아미노산 잔기 수가 증가함에 따라 그 용해도가 미묘하게 변하므로 적당한 용매를 찾아 내는 것이 점점 어려워져, 그에 따라 목적 펩티드와 미반응물이나 부생성물과의 분리도 점점 더 어려워진다. 특히 LH-RH 및 그 유도체의 4번째 세린 잔기는 라세미화하기 쉬우므로 불순물로 잔존하며, 또한 원료의 회수가 불가능한 점 등, 반응 후의 처리가 곤란하여 더욱 비경제적이기 때문에 공업적으로 충분히 만족할 수 없다.However, in liquid phase synthesis, the solubility of the peptide changes slightly as the number of amino acid residues of the peptide increases, making it difficult to find a suitable solvent, thereby making it difficult to separate the target peptide from the unreacted or by-product. In particular, the fourth serine residue of LH-RH and its derivatives are easily racemized and thus remain as impurities and are not economically satisfactory since the treatment after the reaction is difficult and more economical, such as recovery of raw materials is impossible.

[발명의 개시][Initiation of invention]

본 발명의 과제는 LH-RH 유도체를 효율적으로 대량, 또한 저가로 제조하는 방법을 제공하는 데 있다.An object of the present invention is to provide a method for efficiently and inexpensively producing LH-RH derivatives.

상기 과제를 해결하기 위하여 예의 연구를 거듭한 결과, 효소합성법에 의하여 공업적 생산에 적합한 LH-RH 유도체의 제조방법을 알아내고, 본 발명을 완성하였다.As a result of intensive studies in order to solve the above problems, a method for producing an LH-RH derivative suitable for industrial production by an enzyme synthesis method was found and the present invention was completed.

본 발명은 의약으로서 유용한 펩티드인 LH-RH 유도체를 효소를 이용하여 효율적으로 제조하는 방법에 관한 것이다.The present invention relates to a method for efficiently preparing an LH-RH derivative which is a peptide useful as a medicament using an enzyme.

본 발명은 하기 일반식(1)로 표시되는 펩티드 단편과, 하기 일반식(2)로 표시되는 펩티드 단편을 키모트립신 또는 키모트립신 유사 효소로 이루어지는 군에서 선택되는 효소의 존재하에서 반응시키는 것을 특징으로 하는 일반식(3)으로 표시되는 LH-RH 유도체의 제조방법이다.The present invention is characterized in that the peptide fragment represented by the following general formula (1) and the peptide fragment represented by the following general formula (2) are reacted in the presence of an enzyme selected from the group consisting of chymotrypsin or chymotrypsin-like enzyme. It is a manufacturing method of the LH-RH derivative represented by General formula (3).

pGlu-His-Trp-OR1(1)pGlu-His-Trp-OR 1 (1)

H-Ser-Tyr-X-Leu-Arg-Pro-Y (2)H-Ser-Tyr-X-Leu-Arg-Pro-Y (2)

pGlu-His-Trp-Ser-Tyr-X-Leu-Arg-Pro-Y (3)pGlu-His-Trp-Ser-Tyr-X-Leu-Arg-Pro-Y (3)

상기 식에서,Where

R1은 저급 알킬을 나타내고,R 1 represents lower alkyl,

X는 D-Leu, D-Ser(But), D-Trp, (2-나프틸)-D-Ala, 및 Gly로 이루어지는 군에서 선택되는 아미노산을 나타내고,X represents an amino acid selected from the group consisting of D-Leu, D-Ser (But), D-Trp, (2-naphthyl) -D-Ala, and Gly,

Y는 Gly-NH2, Azgly(아자글리신)-NH2또는 NHR2(R2는 저급 알킬이다)을 나타낸다.Y represents Gly-NH 2 , Azgly (azaglycine) -NH 2 or NHR 2 (R 2 is lower alkyl).

여기서, 상기 R1은 탄소수 1 내지 3 알킬기이며, R2는 탄소수 1 내지 3 알킬기인 것을 특징으로 한다. 또한, 상기 키모트립신 또는 키모트립신 유사 효소로 이루어지는 군에서 선택되는 효소가 키모트립신인 것을 특징으로 한다.Here, R 1 is a C1-3 alkyl group, R 2 It is characterized in that the C1-3 alkyl group. In addition, the enzyme selected from the group consisting of the chymotrypsin or chymotrypsin-like enzyme is characterized in that the chymotrypsin.

또한, 본 발명은 하기 일반식(4)로 표시되는 펩티드 단편과, 하기 일반식(5)로 표시되는 펩티드 단편을 키모트립신 또는 키모트립신 유사 효소로 이루어지는 군에서 선택되는 효소의 존재하에서 물 또는 완충용액과 유기용매를 혼합한 용매에서 반응시키는 것을 특징으로 하는 일반식(6)으로 표시되는 LH-RH 유도체의 제조방법이다.In addition, the present invention provides a peptide fragment represented by the following general formula (4) and the peptide fragment represented by the following general formula (5) in the presence of an enzyme selected from the group consisting of chymotrypsin or chymotrypsin-like enzyme in the presence of water or buffer It is a manufacturing method of the LH-RH derivative represented by General formula (6) characterized by making it react with the solvent which mixed the solution and the organic solvent.

pGlu-His-Trp-OR1(4)pGlu-His-Trp-OR 1 (4)

H-Ser-Tyr-X-Leu-Arg-Pro-Y (5)H-Ser-Tyr-X-Leu-Arg-Pro-Y (5)

pGlu-His-Trp-Ser-Tyr-X-Leu-Arg-Pro-Y (6)pGlu-His-Trp-Ser-Tyr-X-Leu-Arg-Pro-Y (6)

상기 식에서,Where

R1은 저급 알킬을 나타내고,R 1 represents lower alkyl,

X는 D-Leu, D-Ser(But), D-Trp, (2-나프틸)-D-Ala, 및 Gly로 이루어지는 군에서 선택되는 아미노산을 나타내며,X represents an amino acid selected from the group consisting of D-Leu, D-Ser (But), D-Trp, (2-naphthyl) -D-Ala, and Gly,

Y는 Gly-NH2, Azgly-NH2또는 NHR2(R2는 저급 알킬이다)를 나타낸다.Y represents Gly-NH 2 , Azgly-NH 2 or NHR 2 (R 2 is lower alkyl).

여기서, 상기 물 또는 완충용액과 유기용매를 혼합한 용매가 물 또는 완충용액과 수혼화성 유기용매와의 혼합용매, 또는 물이나 완충용액을 물과 부분적으로 혼화하는 유기용매로 포화시킨 혼합용매인 것을 특징으로 한다.Wherein the solvent in which the water or the buffer solution and the organic solvent are mixed is a mixed solvent of water or the buffer solution and the water miscible organic solvent, or a mixed solvent saturated with an organic solvent that partially mixes the water or the buffer solution with water. It features.

또한, 본 발명은 하기 일반식(7)로 표시되는 펩티드 단편과, 하기 일반식(8)로 표시되는 펩티드 단편을 키모트립신 또는 키모트립신 유사 효소로 이루어지는 군에서 선택되는 효소를 고정화한 고정화 효소의 존재하에서, 물 또는 완충용액과 유기용매를 혼합한 용매속에서 반응시키는 것을 특징으로 하는 일반식(9)로 표시되는 LH-RH 유도체의 제조방법이다.In addition, the present invention provides an immobilized enzyme obtained by immobilizing an enzyme selected from the group consisting of a peptide fragment represented by the following general formula (7) and a peptide fragment represented by the following general formula (8): chymotrypsin or chymotrypsin-like enzyme. In the presence of water, a method for producing an LH-RH derivative represented by the formula (9), characterized in that the reaction is carried out in a mixed solvent of water or a buffer solution and an organic solvent.

pGlu-His-Trp-OR1(7)pGlu-His-Trp-OR 1 (7)

H-Ser-Tyr-X-Leu-Arg-Pro-Y (8)H-Ser-Tyr-X-Leu-Arg-Pro-Y (8)

pGlu-His-Trp-Ser-Tyr-X-Leu-Arg-Pro-Y (9)pGlu-His-Trp-Ser-Tyr-X-Leu-Arg-Pro-Y (9)

상기 식에서,Where

R1은 저급 알킬을 나타내고,R 1 represents lower alkyl,

X는 D-Leu, D-Ser(But), D-Trp, (2-나프틸)-D-Ala, 및 Gly로 이루어지는 군에서 선택되는 아미노산을 나타내며,X represents an amino acid selected from the group consisting of D-Leu, D-Ser (But), D-Trp, (2-naphthyl) -D-Ala, and Gly,

Y는 Gly-NH2, Azgly-NH2또는 NHR2(R2는 저급 알킬이다)을 나타낸다.Y represents Gly-NH 2 , Azgly-NH 2 or NHR 2 (R 2 is lower alkyl).

본 명세서에 있어서, LH-RH 유도체란 일반식(10)(서열번호 1)In the present specification, LH-RH derivative is a general formula (10) (SEQ ID NO: 1)

pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2(10)pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH 2 (10)

으로 표시되는 LH-RH의 6번째 및 10번째 글라이신이 다른 아미노산, 특수 아미노산 또는 수식 아미노산으로 치환된 것을 의미한다. 6번째의 글라이신(이하, X라 한다)에 해당하는 위치의 아미노산은 D-형 아미노산 또는 이들이 수식된 수식 아미노산이면 되고, 특별히 한정되지 않는다. 구체적인 D-형 아미노산으로는, D-Leu, D-Trp, D-Ala, D-Phe, D-Val, D-His 등의 D-형 아미노산을 들 수 있으며, 수식 아미노산으로는, D-Ser(But), (2-나프틸)-D-Ala 등을 들 수 있다. 또한, X는 L-형 아미노산이어도 된다. X가 상기의 D-형 아미노산 및 수식 아미노산인 경우에는 D-Leu, D-Trp, D-Ala, D-Ser(But) 및 (2-나프틸)-D-Ala로 이루어지는 군에서 선택되는 것이 바람직하며, L-형 아미노산인 경우에는 글라이신인 것이 바람직하다. 10번째의 글라이신(이하, Y라 한다)은 Gly-NH2, Azgly-NH2또는 NHR2(R2는 저급 알킬이다.)인 것이 바람직하다.It means that the 6th and 10th glycine of LH-RH represented by is substituted with other amino acids, special amino acids or modified amino acids. The amino acid at the position corresponding to the sixth glycine (hereinafter referred to as X) may be a D-type amino acid or a modified amino acid in which these are modified, and is not particularly limited. Specific D-type amino acids include D-type amino acids such as D-Leu, D-Trp, D-Ala, D-Phe, D-Val, and D-His, and as modified amino acids, D-Ser (But), (2-naphthyl) -D-Ala, etc. are mentioned. In addition, X may be an L-type amino acid. When X is the above D-type amino acid and modified amino acid, it is selected from the group consisting of D-Leu, D-Trp, D-Ala, D-Ser (But) and (2-naphthyl) -D-Ala In the case of L-type amino acids, glycine is preferable. The tenth glycine (hereinafter referred to as Y) is preferably Gly-NH 2 , Azgly-NH 2 or NHR 2 (R 2 is lower alkyl).

「저급 알킬」이란, 탄소원자가 1 내지 3개의 알킬을 의미하며, 구체적으로는 메틸, 에틸, 프로필 및 이소프로필을 들 수 있다. R1은 메틸 또는 에틸기, R2는 에틸 또는 메틸기인 것이 바람직하다."Lower alkyl" means alkyl having 1 to 3 carbon atoms, and specific examples thereof include methyl, ethyl, propyl and isopropyl. R 1 is preferably a methyl or ethyl group, and R 2 is an ethyl or methyl group.

또한, 본 명세서에 있어서, 아미노산, 펩티드, 보호기, 용매, 그 밖에 관하여 약호로 표시하는 경우, 국제순수 및 응용화학연합(IUPAC), 국제생화학연합(IUB)의 규정, 또는 해당 분야에 있어서의 관용기호에 따르는 것으로 한다. 그 예를 이하에 나타낸다. 단, 아미노산 등에 관하여 광학이성질체가 있을 수 있는 경우에는, 특별히 명시하지 않으면 L-형을 나타내는 것으로 한다.In addition, in this specification, when abbreviated about amino acid, a peptide, a protecting group, a solvent, and others, the regulation of International Pure and Applied Chemistry (IUPAC), the International Biochemical Union (IUB), or the tolerance in the said field | area. We shall follow preference. The example is shown below. However, when there exists an optical isomer with respect to an amino acid etc., unless otherwise indicated, it shall show L-form.

Tyr : 티로신 잔기(Tyrosine residue)Tyr: Tyrosine residue

Gly : 글리신 잔시(Glycine residue)Gly: Glycine residue

Azgly : 아자글리신 잔기(Azaglycine residue)Azgly: Azaglycine residue

Glu : 글루타민산 잔기(Glutamic acid residue)Glu: Glutamic acid residue

pGlu : 피로글루타민산 잔기(Pyroglutamic acid residue)pGlu: Pyroglutamic acid residue

Ser : 세린 잔기(Serine residue)Ser: Serine residue

Arg : 아르기닌 잔기(Arginine residue)Arg: Arginine residue

Pro : 프롤린 잔기(Proline residue)Pro: Proline residue

Leu : 루이신 잔기(Leucine residue)Leu: Leucine residue

His : 히스티딘 잔기(Histidine residue)His: Histidine residue

Ala : 알라닌(Alanine residue)Ala: Alanine residue

Trp : 트립토판 잔기(Tryptophan residue)Trp: Tryptophan residue

Et : 에틸(Ethyl)Et: Ethyl

Boc : t-부톡시카르보닐(t-Butoxycarbonyl)Boc: t-Butoxycarbonyl

Aoc : t-아밀옥시카르보닐(t-Amyloxycarbonyl)Aoc: t-amyloxycarbonyl

Bz : 벤질(Benzyl)Bz: Benzyl

Z : 벤질옥시카르보닐(Benzyloxycarbonyl)Z: Benzyloxycarbonyl

Tos : 토실(Tosyl)Tos: Tosyl

OMe : 메틸에스테르(Methyl ester)OMe: Methyl ester

OBz : 벤질에스테르(Benzyl ester)OBz: Benzyl ester

OSu : N-하이드록시석신이미드에스테르(N-Hydroxysuccinimide ester)OSu: N-Hydroxysuccinimide ester

TFA : 트리플루오로초산(Trifluoroacetic acid)TFA: Trifluoroacetic acid

THF : 테트라하이드로퓨란(Tetrahydrofuran)THF: Tetrahydrofuran

DMF : 디메틸포름아마이드(Dimethylformamide)DMF: Dimethylformamide

DCC : 디시클로헥실카르보디이미드(Dicyclohexylcarbodimide)DCC: Dicyclohexylcarbodimide

WSC : N-에틸-N'-디메틸아미노프로필카르보디이미드(N-ethyl-N'- dimethylaminopropyl-carbodiimide)WSC: N-ethyl-N'-dimethylaminopropylcarbodiimide

HOSu : N-하이드록시석시니미드(N-hydroxysucciniimide)HOSu: N-hydroxysucciniimide

HOBt : 1-하이드록시벤조트리아졸(1-Hydroxybenzotriazol)HOBt: 1-hydroxybenzotriazole (1-Hydroxybenzotriazol)

MeOH : 메탄올(Methanol)MeOH: Methanol

EtOH : 에탄올(Ethanol)EtOH: Ethanol

AcOH : 초산(Acetic acid)AcOH: Acetic acid

일반식(1)로 표시되는 펩티드 단편은 일반식(3)으로 표시되는 LH-RH 유도체의 아미노산 서열 1번부터 3번 아미노산 잔기에 해당하는 것이다. 또한, 일반식(2)로 표시되는 펩티드 단편은 일반식(3)으로 표시되는 LH-RH 유도체의 아미노산 서열의 4번째 이하의 아미노산 잔기에 해당하는 것이다.The peptide fragment represented by general formula (1) corresponds to amino acid residues 1 to 3 of amino acid sequence of the LH-RH derivative represented by general formula (3). In addition, the peptide fragment represented by General formula (2) corresponds to the 4th or less amino acid residue of the amino acid sequence of the LH-RH derivative represented by General formula (3).

일반식(1)로 표시되는 펩티드 단편 또는 일반식(2)로 표시되는 펩티드 단편은 각각 공지의 펩티드합성의 통상적인 수단에 따라 합성할 수 있다. 예를 들면, 「더 펩티드(The Peptides)」제 1권(1966년)[Schreder and Luhke저, Academic Press, New York, U.S.A.], 또는 「펩티드합성」[이즈미야 외 저, 마루젠주식회사(1975년)]에 기재되어 있는 방법에 따라, 예를 들면 아지도(azido)법, 산클로라이드법, 산무수물법, 혼합산무수물법, DCC법, 활성에스테르법(p-니트로페닐에스테르법, N-하이드록시석시니미드에스테르법, 시아노메틸에스테르법 등), 우드워드시약 K(Woodward reagent K)를 이용하는 방법, 카르보이미다졸법, 산화환원법, DCC-첨가물(HONB, HOBt, HOSu)법, 코팅법 등에 의하여 합성할 수 있다. 상기와 같은 일반적인 펩티드의 합성법에 의하여, 예를 들면, C 말단 아미노산에 아미노산 서열에 따라 순차적으로 1개씩 아미노산을 축합시키는 소위 단계적 신장법에 의하여, 또는 여러개의 단편으로 나누어 각 단편을 합성하여 그것들을 커플링시키는 단편축합법에 의하여 제조할 수 있다.The peptide fragment represented by the general formula (1) or the peptide fragment represented by the general formula (2) can be synthesized according to conventional means for known peptide synthesis, respectively. For example, "The Peptides" Vol. 1 (1966) [Schreder and Luhke, Academic Press, New York, USA], or "Peptide Synthesis" by Izumiya et al., Maruzen Corporation (1975) According to the method described in []], for example, the azido method, the acid chloride method, the acid anhydride method, the mixed acid anhydride method, the DCC method, the active ester method (p-nitrophenyl ester method, N-hydride) Oxysuccinimide ester method, cyanomethyl ester method, etc.), woodward reagent K, carbodiimidazole method, redox method, DCC-additive (HONB, HOBt, HOSu) method, coating method, etc. It can synthesize | combine by. By the synthesis of general peptides as described above, for example, by a so-called stepwise stretching method that condenses amino acids one by one according to the amino acid sequence to the C-terminal amino acids, or by dividing into several fragments to synthesize each fragment and It can manufacture by the fragment condensation method to couple.

또한, 상기 일반식(1) 또는 (2)로 표시되는 펩티드 단편의 합성반응 공정에서는, 반응에 관여하지 않는 작용기는 통상의 보호기에 의하여 보호되며, 반응종료 후 보호기는 제거된다. 또한, 반응에 관여하는 작용기는 통상적으로 활성화된다. 이들 각 반응방법은 공지되어 있으며, 이에 사용되는 시약들도 공지의 것에서 적절히 선택하여 얻는다.In addition, in the synthetic reaction step of the peptide fragment represented by the general formula (1) or (2), the functional group not involved in the reaction is protected by a common protecting group, and the protecting group is removed after completion of the reaction. In addition, the functional groups involved in the reaction are usually activated. Each of these reaction methods is known, and the reagents used therein are also appropriately selected from known ones.

아미노기의 보호기로는 벤질옥시카르보닐(Z), t-부틸옥시카르보닐(Boc), t-아밀옥시카르보닐(Aoc), 이소보닐옥시카르보닐, p-메톡시벤질옥시카르보닐, 2-클로로벤질옥시카르보닐, 아다만틸옥시카르보닐, 트리플루오로아세틸, 프탈로일, 포밀(formyl), o-니트로페닐설페닐, 디페닐포스피노티오일 등을 들 수 있다. 아미노기의 보호에는 통상적으로 Boc를 이용하나, D-Ser(But)을 결합하는 경우에는 Z기를 이용하면 But(t-부틸)기를 제거하는 일 없이 Z기만을 제거할 수 있다.Examples of protecting groups for the amino group include benzyloxycarbonyl (Z), t-butyloxycarbonyl (Boc), t-amyloxycarbonyl (Aoc), isobornyloxycarbonyl, p-methoxybenzyloxycarbonyl, 2- Chlorobenzyloxycarbonyl, adamantyloxycarbonyl, trifluoroacetyl, phthaloyl, formyl, o-nitrophenylsulphenyl, diphenylphosphinothioyl and the like. Boc is generally used to protect the amino group, but when combining D-Ser (But), Z group can be used to remove only Z group without removing But (t-butyl) group.

카르복실기의 보호기로는 알킬에스테르(예를 들면, 메틸에스테르, 에틸에스테르, 프로필에스테르, 부틸에스테르, tert-부틸에스테르 등), 벤질에스테르, p-니트로벤질에스테르, 메틸벤질에스테르, p-클로로벤질에스테르, 벤즈하이드릴에스테르, 벤질옥시카르보닐하이드라지드, tert-부틸옥시카르보닐하이드라지드, 트리틸하이드라지드 등을 들 수 있다. 하이드라지드화할 때는 메틸에스테르 또는 에틸에스테르를 사용하는 것이 바람직하다.Examples of protecting groups for carboxyl groups include alkyl esters (eg, methyl esters, ethyl esters, propyl esters, butyl esters, tert-butyl esters, etc.), benzyl esters, p-nitrobenzyl esters, methyl benzyl esters, p-chlorobenzyl esters, Benzhydryl ester, benzyloxycarbonyl hydrazide, tert-butyloxycarbonyl hydrazide, trityl hydrazide and the like. When hydrazide is used, it is preferable to use methyl ester or ethyl ester.

펩티드결합에 관여하는 카르복실기가 활성화된 것으로는, 예를 들면, 대응하는 산클로라이드, 산무수물 또는 혼합 산무수물, 아자이드, 활성에스테르(예를 들면, 펜타클로로페놀, p-니트로페놀, N-하이드록시석신이미드, N-하이드록시벤즈트리아졸, N-하이드록시-5-노보렌-2,3-디카르복시이미드 등의 에스테르) 등을 들 수 있다. 이들 중, 단편을 축합할 때는 라세미화가 적은 아자이드법을 이용하는 것이 바람직하다.Activated carboxyl groups involved in peptide bonds include, for example, the corresponding acid chlorides, acid anhydrides or mixed acid anhydrides, azides, active esters (e.g., pentachlorophenol, p-nitrophenol, N-hydride). Hydroxysuccinimide, esters such as N-hydroxybenztriazole, N-hydroxy-5-novolene-2,3-dicarboxyimide), and the like. Among these, when condensing fragments, it is preferable to use the azide method with little racemization.

또한, 펩티드결합 생성반응은 축합제, 예를 들면, 디시클로헥실카르보디이미드, 카르보디이미다졸 등의 카르보디이미드 시약이나 테트라에틸피로포스페이트 등의 존재하에서 실시할 수 있는 경우도 있다.In addition, the peptide bond generation reaction may be carried out in the presence of a condensation agent, for example, a carbodiimide reagent such as dicyclohexylcarbodiimide, carbodiimidazole, tetraethylpyrophosphate or the like.

종래에는, 단백질 분해효소는 주로 펩티드결합의 절단에 사용되어 왔으나, 그 역반응인 펩티드결합의 생성반응에도 관여할 수 있음은 오래전부터 알려져 있다. 장쇄 펩티드의 효소합성은 그 구조속에 제한된 기질 특이성이 있는 아미노산을 보유하는 경우나, 제한된 기질특이성을 갖는 효소를 이용하는 경우에 한정되므로, 트립신이나 키모트립신과 같은 일반적인 효소는 펩티드의 형성반응에 이용되는 일이 적다. 따라서, 효소반응은 주로 올리고펩티드 등의 비교적 단쇄의 펩티드결합에 이용되는데, 합성조건의 검토에 시간이 필요하다. 이러한 이유로 인하여, 펩티드를 제조하는 경우, 일반적으로는 화학합성이 이용되고 있으며 화학합성에서 부반응이 많은 경우나 반응이 어려운 경우에 효소합성이 시도된다. 효소합성은 조건에 따라서는 화학합성에서의 상기문제점이 해결되어, 대량생산 가능한 완화된 조건에서 행함으로써 매우 유용한 방법이 될 수 있다.Conventionally, proteolytic enzymes have been mainly used for cleavage of peptide bonds, but it has long been known that they can also be involved in the reaction of generating peptide bonds, which is the reverse reaction. Enzyme synthesis of long-chain peptides is limited to having amino acids with limited substrate specificity in the structure or using enzymes with limited substrate specificity. Therefore, general enzymes such as trypsin and chymotrypsin are used to form peptides. Less work Therefore, the enzyme reaction is mainly used for relatively short-chain peptide bonds such as oligopeptides, but it takes time to examine the synthetic conditions. For this reason, in the production of peptides, chemical synthesis is generally used, and enzyme synthesis is attempted when there are many side reactions in chemical synthesis or when the reaction is difficult. Enzyme synthesis can solve the above problems in chemical synthesis depending on the conditions, and can be a very useful method by carrying out under mild conditions capable of mass production.

본 발명은 예의검토를 거듭한 결과, 일반식(1)로 표시되는 펩티드 단편과 일반식(2)로 표시되는 펩티드 단편을 키모트립신 또는 키모트립신 유사 효소의 존재하에서 반응시켜 양자를 결합시킴으로써, 일반식(3)으로 표시되는 LH-RH 유도체를 효율적으로 제조하는데 성공하였다.As a result of intensive examination, the present invention reacts the peptide fragment represented by formula (1) and the peptide fragment represented by formula (2) in the presence of chymotrypsin or chymotrypsin-like enzyme to bind both. It was successful to efficiently prepare the LH-RH derivative represented by the formula (3).

본 발명에서 이용하는 키모트립신은 국제생화학연합(I.U.B.) 효소위원회에 효소번호 EC.3.4.21.1로 등록되어 있는 세린계 단백질 분해효소의 일종으로 소의 췌장에서 얻어지는 효소이다. 키모트립신은 SIGMA사 등에서 시판되고 있다.The chymotrypsin used in the present invention is an enzyme obtained from bovine pancreas, which is a kind of serine proteolytic enzyme registered with enzyme number EC.3.4.21.1 with the International Biochemical Association (I.U.B.) enzyme committee. Chymotrypsin is commercially available from SIGMA.

키모트립신 유사 효소란, 타이로신, 페닐알라닌 등의 방향족을 인식하는 단백질 분해효소를 말하며, 구체적으로는 α-키모트립신 등을 들 수 있다.The chymotrypsin-like enzyme refers to proteolytic enzymes that recognize aromatics such as tyrosine and phenylalanine, and specific examples thereof include α-chymotrypsin.

키모트립신 또는 키모트립신 유사 효소를 이용하는 것이 바람직한 이유는 LH-RH 유도체에 키모트립신 또는 키모트립신 분해효소의 인식부위의 하나인 트립토판이 존재하기 때문이다.It is preferable to use chymotrypsin or chymotrypsin-like enzyme because tryptophan, which is one of the recognition sites of chymotrypsin or chymotrypsin degrading enzyme, exists in the LH-RH derivative.

키모트립신 또는 키모트립신 유사 효소의 반응은 통상적으로 pH가 약 5 내지 10, 바람직하게는 pH가 약 6 내지 9, 더 바람직하게는 pH가 약 7.5 내지 8.5인 완충용액을 함유하는 매질속에서 이루어진다.The reaction of chymotrypsin or chymotrypsin-like enzymes is typically carried out in a medium containing a buffer solution having a pH of about 5 to 10, preferably a pH of about 6 to 9, more preferably a pH of about 7.5 to 8.5.

완충용액을 함유하는 매질이란, 완충용액 자체를 매질로 하는 용매, 후술하는 각종 완충용액과 수혼화성 유기용매와의 혼합용매, 또는 이들 완충용액을 물과 완전하게는 혼화하지 않는 유기용매와의 혼합용매를 말한다.A medium containing a buffer solution is a solvent which uses the buffer solution itself as a medium, a mixed solvent of various buffer solutions and water-miscible organic solvents described below, or an organic solvent which does not completely mix these buffer solutions with water. Say a solvent.

완충용액으로는 pH 값이 상기 범위내의 것이면, 특별히 한정되지 않고 각종의 것을 사용할 수 있다. 예를 들면, 트리스염산완충용액, 맥일베인완충용액, 인산완충용액, 초산암모늄완충용액, 아트킨스 & 팬틴완충용액, 베로날완충용액 등을 들 수 있다.As a buffer solution, if pH value is in the said range, it will not specifically limit but various things can be used. For example, a tris hydrochloric acid buffer solution, a maxyl vane buffer solution, a phosphate buffer solution, an ammonium acetate buffer solution, an Atkins & pantin buffer solution, a veronal buffer solution, etc. are mentioned.

상기와 같은 완충용액을 반응매질로 사용하는 경우, 그 완충용액은 통상 수혼화성 유기용매와 혼합하여 사용된다. 여기서 사용되는 수혼화성 유기용매로는, 예를 들면, 디메틸포름아마이드(DMF), 디메틸설폭사이드(DMSO), 디메틸이미다졸이디논(DMI), 헥사메틸포스포릴트리아마이드(HMPA), 메탄올(MeOH), 에탄올(EtOH) 등을 들 수 있다. 바람직한 것은 디메틸포름아마이드, 메탄올 및 에탄올이다.When such a buffer solution is used as the reaction medium, the buffer solution is usually used in admixture with a water miscible organic solvent. As the water-miscible organic solvent used here, for example, dimethylformamide (DMF), dimethyl sulfoxide (DMSO), dimethylimidazoleidinone (DMI), hexamethylphosphoryltriamide (HMPA), methanol ( MeOH), ethanol (EtOH), etc. are mentioned. Preferred are dimethylformamide, methanol and ethanol.

또한, n-부탄올(1-BuOH), 에틸아세테이트(EtOAc) 등의 물과 완전하게는 혼화하지 않는 유기용매를 사용할 수도 있다. 물과 완전하게는 혼화하지 않는 유기용매를 사용하는 경우에는, 후처리 조작에서 분배 크로마토그래피의 조작을 용이하게 하기 위하여, 부탄올을 사용하는 것이 바람직하다.In addition, an organic solvent which is not completely miscible with water such as n-butanol (1-BuOH) and ethyl acetate (EtOAc) may be used. In the case of using an organic solvent which is not completely miscible with water, it is preferable to use butanol in order to facilitate the operation of partition chromatography in the post-treatment operation.

이들 유기용매는 단독으로 사용해도 되며, 또는 2종 이상을 조합하여 사용해도 된다.These organic solvents may be used independently, or may be used in combination of 2 or more type.

키모트립신 또는 키모트립신 유사 효소는 물 또는 완충용액 단독의 용매가 아니라, 이들과 유기용매를 혼합한 용매에서 반응시키면 목적으로 하는 펩티드의 수율이 현저히 향상된다.The chymotrypsin or chymotrypsin-like enzyme is not a solvent of water or a buffer solution alone, but is reacted in a solvent in which these and organic solvents are mixed. The yield of the desired peptide is significantly improved.

수혼화성 유기용매의 물 또는 완충용액과의 혼합비율은 일반적으로는 50 용량% 이하가 반응성 면에서 바람직하나, 고정화 효소, 예를 들면, 셀라이트를 이용한 고정화된 키모트립신을 이용하는 경우에는 80 용량% 이상인 것이 바람직하다. 또한, 물과 완전히는 혼화하지 않는 유기용매를 이용하는 경우에는, 상기 유기용매의 포화수를 이용하면 효소의 반응효율이 높다는 이점이 있다.The mixing ratio of water-miscible organic solvent with water or buffer solution is generally preferably 50 vol% or less in terms of reactivity, but 80 vol% using immobilized chymotrypsin using an immobilizing enzyme such as celite. It is preferable that it is above. In addition, in the case of using an organic solvent that is not completely miscible with water, the use of saturated water of the organic solvent has the advantage that the reaction efficiency of the enzyme is high.

상술의 효소반응은 통상 키모트립신 또는 키모트립신 유사 효소가 작용하는 온도범위, 즉 일반적으로는 약 0 내지 50℃, 바람직하게는 약 0 내지 20℃의 범위에서 행한다. 약 10℃에서 반응시키면 동시에 일어나는 가수분해반응을 억제할 수 있는 효과가 있다.The above enzymatic reaction is usually carried out in the temperature range in which the chymotrypsin or chymotrypsin-like enzyme acts, generally in the range of about 0 to 50 ° C, preferably about 0 to 20 ° C. Reaction at about 10 ℃ has the effect of suppressing the hydrolysis reaction that occurs at the same time.

키모트립신 또는 키모트립신 유사 효소의 사용량은, 특별히 한정되지 않고 반응조건에 따라 적절히 조정할 수 있다. 예를 들면, 기질 50g에 대하여 약 50 내지 100㎎의 키모트립신을 이용하면 1시간에 약 75 내지 85%의 범위수율로 목적 펩티드를 합성할 수 있다.The amount of chymotrypsin or chymotrypsin-like enzyme is not particularly limited and can be appropriately adjusted according to the reaction conditions. For example, using about 50-100 mg of chymotrypsin with respect to 50 g of substrate can be used to synthesize the desired peptide in a range yield of about 75-85% in one hour.

또한, 일반식(2)로 표시되는 펩티드 단편 1몰당, 일반식(1)로 표시되는 펩티드 단편을 통상 1 내지 5몰, 바람직하게는 2 내지 4몰 사용한다.Moreover, 1-5 mol, preferably 2-4 mol of peptide fragments represented by General formula (1) are normally used per mol of peptide fragments represented by General formula (2).

본 발명의 방법으로는, 키모트립신 또는 키모트립신 유사 효소를 물 또는 적당한 완충용액에 용해하여 사용해도 되고, 또는 일반적인 방법, 예를 들면, 운반체결합법, 가교법, 포괄법, 기타 방법에 의하여 고정화하여 고정화 효소로서 사용해도 된다. 운반체결합법에 있어서 이용하는 운반체로는, 셀룰로스, 덱스트린, 아가로스와 같은 다당류의 유도체, 폴리아크릴아마이드 젤, 셀라이트, 다공성유리 등을 들 수 있다. 가교법에 있어서 이용하는 가교시약으로는, 예를 들면, 글루타르알데히드, 비스디아조벤지딘, N,N-폴리메틸렌비스요드아세트아마이드, N,N-에틸렌비스말레이미드 등을 들 수 있다. 포괄법에서 이용하는 소재로는, 폴리아크릴아미드 젤, 폴리아크릴알콜 젤, 전분, 곤약분, 나일론, 폴리우레아, 폴리스틸렌, 에틸셀룰로스, 콜로디온, 질산 셀룰로스 등을 들 수 있다. 단, 고정화법은 이들을 이용한 방법에 전혀 한정되지 않는다.As the method of the present invention, chymotrypsin or chymotrypsin-like enzyme may be dissolved in water or a suitable buffer solution, or may be immobilized by a general method such as a carrier binding method, a crosslinking method, a comprehensive method, or other methods. May be used as an immobilizing enzyme. Examples of the carrier used in the carrier bonding method include cellulose, dextrin, derivatives of polysaccharides such as agarose, polyacrylamide gels, celite, porous glass, and the like. Examples of the crosslinking reagent used in the crosslinking method include glutaraldehyde, bisdiazobibenzidine, N, N-polymethylenebisiodacetamide, N, N-ethylenebismaleimide, and the like. As a raw material used by a comprehensive method, polyacrylamide gel, polyacryl alcohol gel, starch, konjac powder, nylon, polyurea, polystyrene, ethyl cellulose, collodione, cellulose nitrate, etc. are mentioned. However, the immobilization method is not limited to the method using these at all.

본 발명의 제조방법으로는, 예를 들면, 이하와 같이 하여 하기 식(11)As a manufacturing method of this invention, it is following formula (11) as follows, for example.

pGlu-His-Trp-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt (11)pGlu-His-Trp-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-NHEt (11)

으로 표시되는 LH-RH 유도체를 얻을 수 있다.The LH-RH derivative represented by can be obtained.

즉, 소정량의 하기 식(12)로 표시되는 펩티드 단편That is, the peptide fragment represented by following formula (12) of predetermined amount

pGlu-His-Trp-OMe (12)pGlu-His-Trp-OMe (12)

와 소정량의 하기 식(13)으로 표시되는 펩티드 단편And a peptide fragment represented by the following formula (13) in a predetermined amount:

H-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt (13)H-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-NHEt (13)

을 소정의 활성을 갖는 키모트립신의 존재하에서, n-부탄올포화수 중, pH 7.8 부근에서, 약 10℃에서 1시간 정도 교반함으로써, 상기 LH-RH 유도체를 얻을 수 있다. 키모트립신의 활성은 약 1,000 국제단위(U)/㎎ 이상인 것이 후공정에서의 제거가 용이하므로 바람직하다. 이 반응시 사용하는 상기 식(12)로 표시되는 펩티드 단편과 상기 식(13)으로 표시되는 펩티드 단편의 몰비는 약 3:1로 사용하면 수율이 높다. 또한, 상기와 같이 물 또는 완충용액 등에 용해하여 반응액에 효소를 첨가하는 대신, 예를 들면, 키모트립신을 통상의 방법에 따라 아가로스에 고정하여, 고정화 효소로서 이용해도 된다. 고정화 효소를 이용하면 반응종료 후에 반응액을 글래스필터 등의 필터를 통과함으로써 반응액으로부터 용이하게 제거할 수 있는 동시에 재사용이 가능하다.In the presence of chymotrypsin having predetermined activity, the LH-RH derivative can be obtained by stirring at about 10 ° C. for about 1 hour in saturated water of n-butanol. The activity of chymotrypsin is preferably about 1,000 international units (U) / mg or more because it is easy to remove in a later step. The molar ratio of the peptide fragment represented by the formula (12) and the peptide fragment represented by the formula (13) used in this reaction is about 3: 1, and the yield is high. In addition, instead of dissolving in water or a buffer solution and adding the enzyme to the reaction solution as described above, for example, chymotrypsin may be fixed to agarose according to a conventional method and used as an immobilized enzyme. By using the immobilized enzyme, the reaction solution can be easily removed from the reaction solution by passing through a filter such as a glass filter after completion of the reaction, and can be reused.

이상과 같이 하여, 상기 LH-RH 유도체를 얻을 수 있으며, 얻어진 LH-RH 유도체는 이하와 같이 하여 정제할 수 있다.As mentioned above, the said LH-RH derivative can be obtained and the obtained LH-RH derivative can be refine | purified as follows.

본 발명의 방법에 의하여 제조된 LH-RH 유도체는 통상의 방법에 따라 탈염, 정제할 수 있다. 여기서 탈염은 염류와의 분자크기의 상이함을 이용하는 다양한 방법, 예를 들면, 젤 여과, 한외 여과, 투석 등에 의하여 행할 수 있다. 구체적으로는 셀룰로스아세테이트제의 막 등을 이용한 한외여과, 세파덱스 LH-20, 세파덱스-60, 세파덱스 G-25 등의 세파덱스 칼럼을 이용한 젤 여과, DEAE-셀룰로스 등을 이용한 이온교환 크로마토그래피 등에 의하여 행할 수 있다. 또한, 정제에 있어서는 서로 혼합하지 않는 2종류의 액체(예를 들면, 물-n-부탄올 등)을 이용하여 이들 2 액상간의 분배계수의 차이를 이용하는 분배 크로마토그래피, 실리카 젤 등을 고정상으로 하는 순상 크로마토그래피나 ODS-실리카 젤 등을 고정상으로 하는 역상 크로마토그래피 등의 고속액체 크로마토그래피(HPLC) 등을 사용할 수 있다.The LH-RH derivative prepared by the method of the present invention can be desalted and purified according to a conventional method. Here, desalting can be performed by various methods utilizing the difference in molecular size from salts, for example, gel filtration, ultrafiltration, dialysis and the like. Specifically, ultrafiltration using membranes made of cellulose acetate, gel filtration using Sephadex columns such as Sephadex LH-20, Sephadex-60, Sephadex G-25, ion exchange chromatography using DEAE-cellulose, and the like. Or the like. In the refining process, two types of liquids (eg, water-n-butanol, etc.) which are not mixed with each other are used, and the chromatographic chromatography using silica gel and the like as the stationary phase using the difference in the partition coefficient between these two liquid phases is used. High performance liquid chromatography (HPLC), such as chromatography or reversed phase chromatography using ODS-silica gel as the stationary phase, can be used.

예를 들면, 본 발명의 방법에 의하여 제조한 LH-RH 유도체는 친수성이므로, 상기와 같은 물과 완전하게는 혼화하지 않는 유기용매를 이용하여, 이하와 같이 하여 정제할 수 있다. 상술한 바와 같이 반응시킨 반응 혼합물을 유기용매로 추출하고, 추출액에 물을 첨가하여 분배하고, 에테르 등의 용매로 고체화한다. 추출에 이용하는 유기용매로는, n-부탄올(n-BuOH) 등이 바람직하다. 이들 용매는 극성이 높으므로 추출효율이 높고, 또한 물과 섞이지 않는 점에서 다음의 공정에서 행하는 분배 크로마토그래피에 있어서 편리하기 때문이다For example, since the LH-RH derivative prepared by the method of the present invention is hydrophilic, it can be purified as follows using an organic solvent which is not completely miscible with water as described above. The reaction mixture reacted as described above is extracted with an organic solvent, water is added to the extract and partitioned, and solidified with a solvent such as ether. As an organic solvent used for extraction, n-butanol (n-BuOH) etc. are preferable. This is because these solvents have high polarity, and thus, extraction efficiency is high, and since they are not mixed with water, they are convenient for the distribution chromatography performed in the next step.

반응혼합액(1,200mL)에 약 1/4분량의 n-부탄올(300mL)을 첨가하여, 반응혼합액의 물과의 분배 크로마토그래피를 행한다. n-부탄올에 의한 추출은 적절히 반복해도 된다. 수층과 유기층은 각각 분리하여 농축한다. 이때, 수층으로부터는 상기(7)의 펩티드 단편이 회수되므로 재차 반응에 사용할 수 있다.About 1/4 part of n-butanol (300 mL) is added to the reaction mixture (1,200 mL), and the chromatography of the reaction mixture with water is performed. Extraction with n-butanol may be appropriately repeated. The aqueous and organic layers are separated and concentrated respectively. At this time, since the peptide fragment of said (7) is collect | recovered from an aqueous layer, it can be used for reaction again.

분배 크로마토그래피에 의하여 유기층에서 얻어진 조정제물은 디에틸에테르, 초산에틸 등에 의하여 고체화하는 것이, LH-RH 유도체가 이들 용매에 난용성인 점에서 볼 때 바람직하다. 이어서, 이 고체화된 조정제물을, 예를 들면, 초산암모늄 등의 적당한 완충용액에 용해하고, 적당한 고정상과 이동상을 이용하여 칼럼 크로마토그래피로 분획한다. 고정상으로서 CM 셀룰로스와 같은 약양이온 교환수지, SP와 같은 강양이온 수지 등을 이용하면 LH-RH에 함유되는 아르기닌 잔기에 의한 상호작용을 얻을 수 있다. 이동상으로서는 고체화한 조정제물을 용해한 것과 같은 완충용액을 이용하여, 염농도를 직선구배로 높이면 수율이 높다는 이점이 있다. 구체적으로는, 0.01M의 초산암모늄 수용액과 0.1M의 초산암모늄 수용액을 이용할 수 있다. 얻어진 용출액을 고정상과 용출액을 적당히 선택하여 HPLC로 정제함으로써 얻을 수 있다. HPLC에 있어서는 고정상으로서 TSK 젤 ODS-120T 등의 ODS 실리카칼럼을 사용할 수 있으며, ODS 실리카칼럼의 사용이 최적이다. 또한, 이동상으로서는 0.1% TFA-아세토니트릴 등을 사용할 수 있다. 여기서 아세토니트릴의 함유량은 개시시의 0.1% TFA-20% 아세토니트릴로부터 매분 1%씩 변화시켜, 0.1% TFA-50% 아세토니트릴로 하는 직선농도구배로 하면 목적의 LH-RH 펩티드의 분리가 용이하다. 정제는 상기의 정제방법에 한정되지 않으며, 또한 고정화효소를 사용하는 경우에는 분배 크로마토그래피를 행하지 않고, 이온교환에 들어갈 수 있다.The crude product obtained in the organic layer by partition chromatography is preferably solidified by diethyl ether, ethyl acetate, etc., in view of the fact that the LH-RH derivative is poorly soluble in these solvents. This solidified crude is then dissolved in a suitable buffer such as ammonium acetate and fractionated by column chromatography using a suitable stationary and mobile phase. When a weak cation exchange resin such as CM cellulose or a strong cation resin such as SP is used as the stationary phase, the interaction by the arginine residues contained in LH-RH can be obtained. As a mobile phase, when the buffer solution which melt | dissolved the solidified crude agent was used, when salt concentration is raised with a linear gradient, there exists an advantage that a yield is high. Specifically, 0.01 M ammonium acetate aqueous solution and 0.1 M ammonium acetate aqueous solution can be used. The obtained eluate can be obtained by appropriately selecting the stationary phase and the eluate and purifying by HPLC. In HPLC, ODS silica columns, such as TSK gel ODS-120T, can be used as a stationary phase, and use of ODS silica columns is optimal. In addition, 0.1% TFA-acetonitrile etc. can be used as a mobile phase. Herein, the content of acetonitrile is changed from 0.1% TFA-20% acetonitrile at the start of 1% per minute, and it is easy to separate the target LH-RH peptide by using a straight concentration tool containing 0.1% TFA-50% acetonitrile. Do. Purification is not limited to the above purification method, and in the case of using an immobilized enzyme, ion exchange can be performed without performing distribution chromatography.

본 발명의 방법은 LH-RH 유도체를 제조하기 위한 종래의 기지의 방법에 비하여 이하에 서술하는 것과 같은 이점이 있어, 공업적으로 매우 유용하다.The method of the present invention has the advantages as described below in comparison with the conventional known methods for producing LH-RH derivatives, and is very useful industrially.

A) 효소반응의 성질상 라세미화 등의 부반응을 수반하지 않고 합성할 수 있으므로 정제분리가 용이하다.A) Purification and separation is easy because it can be synthesized without enzymatic reactions such as racemization.

B) 수율이 높고, 또한 미반응의 단편은 회수재이용 가능하므로 경제적으로 유리하다.B) The yield is high and unreacted fragments are economically advantageous since recoverable materials are available.

LH-RH 유도체는 필요에 따라 의약품으로서 허용될 수 있는 염, 예를 들면, 초산염, 염산염, 인산염 등으로 할 수 있다.The LH-RH derivative may be made into a salt, for example, acetate, hydrochloride, phosphate, or the like, which can be accepted as a medicine as necessary.

이하, 본 발명을 실시예를 들어 더욱 구체적으로 설명한다. 단, 본 발명은 이들에 한정되는 것이 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples. However, this invention is not limited to these.

이하의 실시예에 있어서, 얻어진 순수 펩티드의 동정은 고속액체 크로마토그래피(HPLC)의 보유시간의 측정, 선광도의 측정 및 아미노산 분석에 의하여 행하였다. 이들의 측정은 특별히 표시하지 않는 한, 하기의 측정법 및 측정조건에 의하여 행하였다.In the following examples, the obtained pure peptide was identified by the measurement of the retention time of high performance liquid chromatography (HPLC), the measurement of the photosensitivity, and the amino acid analysis. These measurements were performed by the following measuring methods and measurement conditions, unless otherwise indicated.

(1) 고속액체 크로마토그래피(HPLC)(1) High Performance Liquid Chromatography (HPLC)

고속액체 크로마토그래피 분석에는 LC-Module-1(일본워터스리미티드사)을 검출기로 이용하였다.LC-Module-1 (Japan Water Limited) was used as a detector for high performance liquid chromatography analysis.

(HPLC 분석조건)(HPLC analysis condition)

칼럼: TSK gel ODS-120T(4.6×250mm)Column: TSK gel ODS-120T (4.6 × 250 mm)

용출액: 0.1% TFA-아세토니트릴Eluent: 0.1% TFA-acetonitrile

(아세토니트릴을 20%에서 50%까지 매분 1% 변화시키는 직선구배)(Linear gradient to change acetonitrile by 1% per minute from 20% to 50%)

유속: 1mL/minFlow rate: 1mL / min

검출파장: 220nmDetection wavelength: 220 nm

(2) 선광도(2) optical intensity

선광도의 측정에는 DIC-370(일본분광공업사)를 이용하였다.DIC-370 (Japan Spectroscopy Industry Co., Ltd.) was used for the measurement of the linearity.

(선광도 측정조건)(Photometric measurement condition)

광선: Na 램프 589nmRays: Na Lamp 589nm

온도: 20℃Temperature: 20 ℃

층장: 100mmLayer length: 100mm

농도: 5mg/mLConcentration: 5mg / mL

(3) 아미노산 분석(3) amino acid analysis

아미노산 분석은 얻어진 펩티드를 6N의 염산(0.1% 페놀 함유)속에서 110℃에서 20시간 가수분해한 후, 히타치 아미노산 분석장치 L-8500형(히타치제작소)을 이용하여 행하였다.The amino acid analysis was performed by hydrolyzing the obtained peptide in 110N hydrochloric acid (containing 0.1% phenol) at 110 ° C. for 20 hours using Hitachi Amino Acid Analyzer L-8500 (Hitachi Corporation).

실시예 1: pGlu-His-Trp-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt의 제조Example 1 Preparation of pGlu-His-Trp-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-NHEt

(1-1) Boc-Arg(Tos)-Pro-NHEt의 제조(1-1) Preparation of Boc-Arg (Tos) -Pro-NHEt

Boc-Arg(Tos)-OH 214.3g을 THF 150mL 및 DMF 100mL의 혼합용매에 용해시키고, 드라이아이스-에탄올로 -20℃로 냉각시켰다. 다음으로, 이것에 N-메틸모르폴린 35mL을 적하하고, 계속하여 이소부틸클로로포르메이트 66mL를 적하하고, -20℃에서 1분간 교반하여 해당하는 혼합산무수물을 제조하였다. 얻어진 반응액을 H-Pro-NHEt 71.1g을 THF 300mL에 용해시킨 용액과 혼합하여, 0℃에서 5분간, 실온에서 30분간 교반하였다. 그 후, 얻어진 반응혼합액을 감압농축하고, 잔사에 초산에틸 1,200mL(2회)를 첨가하여 물 500mL로 2회 세척한 후, 초산에틸층을 감압농축하였다. 잔사를 에테르로 처리하고, 고체화하여 건조시켰다. 이와 같이 하여 Boc-Arg(Tos)-Pro-NHEt 221.18g(수율 80.0%)가 얻어졌다.214.3 g of Boc-Arg (Tos) -OH was dissolved in a mixed solvent of 150 mL of THF and 100 mL of DMF, and cooled to −20 ° C. with dry ice-ethanol. Next, 35 mL of N-methylmorpholine was dripped at this, 66 mL of isobutyl chloroformates were then dripped, and it stirred at -20 degreeC for 1 minute, and manufactured the corresponding mixed acid anhydride. The obtained reaction solution was mixed with a solution in which 71.1 g of H-Pro-NHEt was dissolved in 300 mL of THF, and stirred at 0 ° C. for 5 minutes and at room temperature for 30 minutes. Thereafter, the obtained reaction mixture was concentrated under reduced pressure, 1,200 mL (2 times) of ethyl acetate was added to the residue, the mixture was washed twice with 500 mL of water, and the ethyl acetate layer was concentrated under reduced pressure. The residue was treated with ether, solidified and dried. Thus, 221.18 g of Boc-Arg (Tos) -Pro-NHEt (yield 80.0%) was obtained.

Boc-Arg(Tos)-Pro-NHEt의 융점, 선광도, TLC의 Rf 및 원소분석값을 하기에 나타내었다.The melting point of Boc-Arg (Tos) -Pro-NHEt, photoluminescence, Rf of TLC and elemental analysis values are shown below.

m.p. : 100∼102℃m.p. : 100 to 102 ° C

[α]D: -30.3(c=1.0, MeOH)[α] D : -30.3 (c = 1.0, MeOH)

Rf : 0.69(BuOH/AcOH/H2O=4/1/5)Rf: 0.69 (BuOH / AcOH / H 2 O = 4/1/5)

원소분석값(C25H40N6O6S·H2O로서)Elemental analysis value (as C 25 H 40 N 6 O 6 SH 2 O)

이론값 C: 52.61% H: 7.42% N: 14.73%Theoretical C: 52.61% H: 7.42% N: 14.73%

측정값 C: 52.85% H: 7.30% N: 14.41%Found: C: 52.85% H: 7.30% N: 14.41%

(1-2) Z-Leu-Arg(Tos)-Pro-NHEt의 제조(1-2) Preparation of Z-Leu-Arg (Tos) -Pro-NHEt

상기(1-1)로 제조한 Boc-Arg(Tos)-Pro-NHEt 110.54g을 디클로로메탄(DCM) 150mL에 용해시켰다. 이것에 빙냉하에서 TFA 150mL를 첨가하여 30분간 실온에서 교반하였다. 얻어진 반응액을 감압농축하고, 잔사에 에테르 1,500mL를 첨가하여 고체화하고 건조시켰다. 이와 같이 하여 H-Arg(Tos)-Pro-NHEt·TFA를 얻었다.110.54 g of Boc-Arg (Tos) -Pro-NHEt prepared in (1-1) was dissolved in 150 mL of dichloromethane (DCM). TFA150mL was added to this under ice cooling, and it stirred at room temperature for 30 minutes. The obtained reaction liquid was concentrated under reduced pressure, 1,500 mL of ether was added to the residue, solidified, and dried. Thus, H-Arg (Tos) -Pro-NHEtTFA was obtained.

전기 탈보호체 H-Arg(Tos)-Pro-NHEt·TFA를 DMF 80mL 및 THF 200mL의 혼합용매에 용해시키고, 냉각하면서 N-메틸모르폴린으로 중화시켰다. 계속해서, Z-Leu-OH 53.06g과 HOSu 23.02g을 THF 200mL에 용해시킨 액 및 WSC 36.4mL를 첨가하여 0℃에서 5분간, 실온에서 하룻밤 교반하였다. 닌히드린으로 확인후, 반응혼합액을 감압농축하였다.The electric deprotector H-Arg (Tos) -Pro-NHEt.TFA was dissolved in a mixed solvent of 80 mL of DMF and 200 mL of THF, and neutralized with N-methylmorpholine while cooling. Subsequently, a solution obtained by dissolving 53.06 g of Z-Leu-OH and 23.02 g of HOSu in 200 mL of THF and 36.4 mL of WSC were added, followed by stirring at room temperature overnight at 0 ° C. for 5 minutes. After confirming with ninhydrin, the reaction mixture was concentrated under reduced pressure.

잔사에 초산에틸 1,500mL를 첨가하고, 물 500mL에서 2회, 포화식염수 500mL에서 2회 세척하였다. 계속해서, 초산에틸층을 감압농축하고, 잔사를 에테르로 처리하여 고체화하고 건조시켰다. 이와 같이 하여 Z-Leu-Arg(Tos)-Pro-NHEt 119.5g(수율 85.1%)가 얻어졌다.1,500 mL of ethyl acetate was added to the residue, and the mixture was washed twice with 500 mL of water and twice with 500 mL of saturated saline. Subsequently, the ethyl acetate layer was concentrated under reduced pressure, and the residue was treated with ether to solidify and dry. Thus, 119.5 g (yield 85.1%) of Z-Leu-Arg (Tos) -Pro-NHEt was obtained.

Z-Leu-Arg(Tos)-Pro-NHEt의 융점, 선광도, TLC의 Rf 및 원소분석값을 하기에 나타내었다.The melting point of Z-Leu-Arg (Tos) -Pro-NHEt, photoluminescence, Rf of TLC and elemental analysis values are shown below.

m.p. : 99∼103℃m.p. : 99-103 ℃

[α]D: -40.6(c=1.0, MeOH)[α] D : -40.6 (c = 1.0, MeOH)

Rf : 0.75(BuOH/AcOH/H2O=4/1/5)Rf: 0.75 (BuOH / AcOH / H 2 O = 4/1/5)

원소분석값(C34H49N7O7S로서)Elemental Analysis Values (as C 34 H 49 N 7 O 7 S)

이론값 C: 58.35% H: 7.06% N: 14.01%Theoretical C: 58.35% H: 7.06% N: 14.01%

측정값 C: 58.40% H: 7.26% N: 13.78%Found C: 58.40% H: 7.26% N: 13.78%

(1-3) Z-D-Ser(But)-Leu-Arg-Pro-NHEt의 제조(1-3) Preparation of Z-D-Ser (But) -Leu-Arg-Pro-NHEt

상기(1-2)로 제조한 Z-Leu-Arg(Tos)-Pro-NHEt 20.99g에 아니솔 32mL를 첨가하고, 계속해서 드라이아이스-에탄올로 -70℃로 냉각하면서 HF 약 200mL를 첨가하여 0℃에서 1시간 교반하였다. 그 후, 감압농축하여 잔사를 에테르로 처리하였다. 석출한 생성물을 여과하고, 수산화나트륨상에서 진공건조하여 H-Leu-Arg-Pro-NHEt·HF를 얻었다.To 20.99 g of Z-Leu-Arg (Tos) -Pro-NHEt prepared in (1-2) was added 32 mL of anisole, followed by addition of about 200 mL of HF while cooling to -70 ° C with dry ice-ethanol. It stirred at 0 degreeC for 1 hour. Thereafter, the residue was concentrated under reduced pressure and the residue was treated with ether. The precipitated product was filtered off and dried in vacuo over sodium hydroxide to give H-Leu-Arg-Pro-NHEt.HF.

Z-D-Ser(But)-OH 8.86g을 THF 100mL에 용해시켰다. 이것을 드라이아이스-에탄올로 -20℃로 냉각시키고, N-메틸모르폴린 3.3mL를 적하하고, 계속하여 이소부틸클로로포메이트 3.96mL를 적하한 후, -20℃에서 1분간 교반하여 해당하는 혼합산무수물을 제조하였다. 얻어진 반응액을 H-Leu-Arg-Pro-NHEt·HF의 DMF 200mL 용액(N-메틸모르폴린으로 중화한 것)과 혼합하여, 0℃에서 5분간, 실온에서 30분간 교반하였다. 그 후, 감압농축하고, 잔사에 물 500mL를 첨가하여 n-부탄올 200mL로 5회 추출하였다. 추출액을 물로 5회 세척한 후, n-부탄올층을 감압농축하고 잔사를 에테르로 처리하여 고체화하였다. 이와 같이 하여 Z-D-Ser(But)-Leu-Arg-Pro-NHEt 22.89g(수율 90.5%)가 얻어졌다.8.86 g of Z-D-Ser (But) -OH was dissolved in 100 mL of THF. This was cooled to -20 DEG C with dry ice-ethanol, 3.3 mL of N-methylmorpholine was added dropwise, and then 3.96 mL of isobutylchloroformate was added dropwise, followed by stirring at -20 DEG C for 1 minute to give a corresponding mixed acid. Anhydrides were prepared. The obtained reaction solution was mixed with a 200 mL solution of H-Leu-Arg-Pro-NHEt.HF (neutralized with N-methylmorpholine), and stirred at 0 ° C for 5 minutes and at room temperature for 30 minutes. Thereafter, the mixture was concentrated under reduced pressure, 500 mL of water was added to the residue, and extracted with 200 mL of n-butanol five times. The extract was washed five times with water, and then the n-butanol layer was concentrated under reduced pressure and the residue was treated with ether to solidify. Thus, 22.89 g (yield 90.5%) of Z-D-Ser (But) -Leu-Arg-Pro-NHEt was obtained.

Z-D-Ser(But)-Leu-Arg-Pro-NHEt의 융점, 선광도, TLC의 Rf 및 원소분석값을 하기에 나타내었다.The melting point of Z-D-Ser (But) -Leu-Arg-Pro-NHEt, photoluminescence, Rf of TLC and elemental analysis values are shown below.

m.p. : 121∼123℃m.p. : 121 ~ 123 ℃

[α]D: -49.0(c=1.0, MeOH)[α] D : -49.0 (c = 1.0, MeOH)

Rf : 0.51(BuOH/AcOH/H2O=4/1/5)Rf: 0.51 (BuOH / AcOH / H 2 O = 4/1/5)

원소분석값(C34H56N8O7로서)Elemental Analysis Values (as C 34 H 56 N 8 O 7 )

이론값 C: 59.28% H:8.19% N: 16.27%Theoretical C: 59.28% H: 8.19% N: 16.27%

측정값 C: 59.01% H: 8.15% N: 16.19%Found C: 59.01% H: 8.15% N: 16.19%

(1-4) Z-Ser-Tyr-OMe의 제조(1-4) Preparation of Z-Ser-Tyr-OMe

Z-Leu-OH 23.9g 및 H-Tyr-OMe 23.2g을 DMF 50mL에 용해시키고, HOSu 12.7g 및 WSC 20mL를 첨가하여 0℃에서 5분간, 실온에서 하룻밤 교반하였다. 닌히드린으로 확인 후, 반응혼합액을 감압농축하였다. 잔사에 에틸아세테이트 500mL를 첨가하고, 1N 염산 200mL에서 2회, 포화중조수 200mL에서 2회, 포화식염수 2회의 순으로 세척하였다. 에틸아세테이트층을 감압농축하고, 잔사를 헥산으로 처리하여 고체화하고 건조시켰다. 이와 같이 하여 Z-Ser-Tyr-OMe 38.44g(수율 92.3%)가 얻어졌다.23.9 g of Z-Leu-OH and 23.2 g of H-Tyr-OMe were dissolved in 50 mL of DMF, and 12.7 g of HOSu and 20 mL of WSC were added, followed by stirring at 0 ° C. for 5 minutes and at room temperature overnight. After confirming with ninhydrin, the reaction mixture was concentrated under reduced pressure. 500 mL of ethyl acetate was added to the residue, followed by washing twice with 200 mL of 1N hydrochloric acid, twice with 200 mL of saturated aqueous sodium bicarbonate, and twice with brine. The ethyl acetate layer was concentrated under reduced pressure, and the residue was treated with hexane to solidify and dried. Thus, 38.44 g (yield 92.3%) of Z-Ser-Tyr-OMe was obtained.

Z-Ser-Tyr-OMe의 융점, 선광도, TLC의 Rf 및 원소분석값을 하기에 나타내었다.The melting point of Z-Ser-Tyr-OMe, photoluminescence, Rf of TLC and elemental analysis are shown below.

m.p. : 49∼53℃(분해)m.p. : 49-53 ° C (decomposition)

[α]D: +2.3(c=1.0, MeOH)[α] D : +2.3 (c = 1.0, MeOH)

Rf : 0.89(BuOH/AcOH/H2O=4/1/5)Rf: 0.89 (BuOH / AcOH / H 2 O = 4/1/5)

원소분석값(C21H24N2O7로서)Elemental Analysis Values (as C 21 H 24 N 2 O 7 )

이론값 C: 60.57% H: 5.81% N: 6.73%Theoretical C: 60.57% H: 5.81% N: 6.73%

측정값 C: 60.88% H: 5.88% N: 6.99%Measured value C: 60.88% H: 5.88% N: 6.99%

(1-5) Z-Ser-Tyr-NHNH2의 제조(1-5) Preparation of Z-Ser-Tyr-NHNH 2

상기(1-4)로 제조한 Z-Ser-Tyr-OMe 38.0g을 메탄올 200mL에 용해시키고, 하이드라진 50g을 첨가하여 실온에서 하룻밤 방치하였다. 그 후, 감압농축하고 메탄올 세척하였다. 이와 같이 하여 Z-Ser-Tyr-NHNH234.2g(수율 90.0%)가 얻어졌다.38.0 g of Z-Ser-Tyr-OMe prepared in (1-4) was dissolved in 200 mL of methanol, 50 g of hydrazine was added, and the mixture was allowed to stand at room temperature overnight. Thereafter, the mixture was concentrated under reduced pressure and washed with methanol. In this way by the Z-Ser-Tyr-NHNH 2 34.2g ( yield 90.0%) it was obtained.

Z-Ser-Tyr-NHNH2의 융점, 선광도, TLC의 Rf 및 원소분석값을 하기에 나타내었다.The melting point of Z-Ser-Tyr-NHNH 2, the photoluminescence, the Rf of TLC and the elemental analysis values are shown below.

m.p. : 194∼197℃m.p. : 194-197 ℃

[α]D: +9.9(c=1.0, DMF)[α] D : +9.9 (c = 1.0, DMF)

Rf : 0.64(BuOH/AcOH/H2O=4/1/5)Rf: 0.64 (BuOH / AcOH / H 2 O = 4/1/5)

원소분석값(C20H24N4O6로서)Elemental Analysis Values (as C 20 H 24 N 4 O 6 )

이론값 C: 57.69% H:5.81% N: 13.45%Theoretical C: 57.69% H: 5.81% N: 13.45%

측정값 C: 57.85% H: 5.83% N: 13.49%Found C: 57.85% H: 5.83% N: 13.49%

(1-6) Z-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt의 제조(1-6) Preparation of Z-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-NHEt

상기(1-3)으로 제조한 Z-D-Ser(But)-Leu-Arg-Pro-NHEt 28.0g을 메탄올 300mL에 용해시키고, 10% 팔라디움/탄소 2.5g의 존재하에서 수소를 첨가하였다. 7시간 실온에서 교반한 후, 촉매를 제거하여 감압농축하고 잔사를 에테르로 처리하였다. 이와 같이 하여 H-D-Ser(But)-Leu-Arg-Pro-NHEt를 얻었다.28.0 g of Z-D-Ser (But) -Leu-Arg-Pro-NHEt prepared in (1-3) was dissolved in 300 mL of methanol, and hydrogen was added in the presence of 10% palladium / 2.5 g of carbon. After stirring for 7 hours at room temperature, the catalyst was removed, concentrated under reduced pressure, and the residue was treated with ether. Thus, H-D-Ser (But) -Leu-Arg-Pro-NHEt was obtained.

상기(1-5)로 제조한 Z-Ser-Tyr-NHNH220.1g을 DMF 150mL에 용해시키고, 드라이아이스-에탄올로 -20℃로 냉각시켰다. 전기 용액에 4N HCl-다이옥산 43.5mL 및 아이소아밀나이트레이드 6.5mL를 첨가하여 아자이드 화합물로 하였다. 또한 트리에틸아민 24.4mL를 첨가하여 중화시켰다. 그 혼합액을 H-D-Ser(But)-Leu-Arg-Pro-NHEt를 포함하는 DMF 150mL 용액으로 옮겨, -20℃에서 2시간, 4℃에서 17시간 교반한 후 농축시켰다. 잔사에 물 500mL를 첨가하여 n-부탄올 200mL로 5회 추출하였다. 물로 5회 세척한 후, n-부탄올층을 감압농축하고 잔사를 에테르로 처리하여 고체화하였다. 이와 같이 하여 Z-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt 33.2g(수율 87.5%)가 얻어졌다.20.1 g of Z-Ser-Tyr-NHNH 2 prepared in (1-5) was dissolved in 150 mL of DMF, and cooled to −20 ° C. with dry ice-ethanol. 43.5 mL of 4N HCl-dioxane and 6.5 mL of isoamyl nitride were added to the above solution to obtain an azide compound. Furthermore, 24.4 mL of triethylamine was added and neutralized. The mixture was transferred to a 150 mL solution of DMF containing HD-Ser (But) -Leu-Arg-Pro-NHEt, stirred at -20 ° C for 2 hours, and at 4 ° C for 17 hours, and then concentrated. 500 mL of water was added to the residue, and extracted with 200 mL of n-butanol five times. After washing five times with water, the n-butanol layer was concentrated under reduced pressure and the residue was treated with ether to solidify. Thus, 33.2 g of Z-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-NHEt (yield 87.5%) was obtained.

Z-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt의 융점, 선광도, TLC의 Rf 및 원소분석값을 하기에 나타내었다.The melting point of Z-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-NHEt, photoluminescence, Rf of TLC and elemental analysis are shown below.

m.p. : 115∼118℃m.p. : 115 ~ 118 ℃

[α]D: -27.6(c=1.0, DMF)[α] D : -27.6 (c = 1.0, DMF)

Rf : 0.36(BuOH/AcOH/H2O=4/1/5)Rf: 0.36 (BuOH / AcOH / H 2 O = 4/1/5)

원소분석값(C46H70N10O11로서)Elemental Analysis Values (as C 46 H 70 N 10 O 11 )

이론값 C: 58.83% H: 7.51% N: 14.91%Theoretical C: 58.83% H: 7.51% N: 14.91%

측정값 C: 58.88% H: 7.55% N: 14.90%Found C: 58.88% H: 7.55% N: 14.90%

(1-7) Z-pGlu-His-OH의 제조(1-7) Preparation of Z-pGlu-His-OH

Z-pGlu-OH 52.6g을 THF 400mL에 용해시켰다. 이 용액을 드라이아이스-에탄올로 -20℃로 냉각시키고, N-메틸모르폴린 22.0mL, 계속하여 이소부틸클로로포메이트 26.4mL를 적하한 후, -20℃에서 1분간 교반하여 해당하는 혼합산무수물을 제조하였다. 얻어진 반응혼합액에 HOSu 25.3g을 첨가하여 30분간 교반하였다. 계속해서 이것에 H-His-OH·HCl 62.9g 및 트리에틸아민(TEA) 28.0mL를 물 400mL에 용해시킨 용액을 첨가하였다. 0℃에서 1시간, 실온에서 하룻밤 교반한 후 감압농축하였다. 잔존수용액을 에틸아세테이트로 세척하고, 수층을 n-부탄올로 추출하였다. 물로 수회 세척한 후, n-부탄올층을 감압농축하고 에테르로 고체화한 후, 물에 용해하여 pH 5로 조정하였다. 이 수용액을 HP-20을 충진한 칼럼(5.0×20cm)에 주입하고, 유출액의 파울리 반응이 ±가 될 때까지 물세척한 후, 메탄올로 용출시켰다. 용출된 메탄올액을 감압농축하고 잔사를 에테르로 처리하였다. 계속해서 메탄올-에테르로 재결정화하였다. 이와 같이 하여 Z-pGlu-His-OH 59.5g(수율 74.3%)가 얻어졌다.52.6 g of Z-pGlu-OH was dissolved in 400 mL of THF. The solution was cooled to -20 DEG C with dry ice-ethanol, 22.0 mL of N-methylmorpholine and 26.4 mL of isobutylchloroformate were added dropwise, followed by stirring at -20 DEG C for 1 minute to give the corresponding mixed acid anhydride. Was prepared. HOSu 25.3g was added to the obtained reaction mixture, and stirred for 30 minutes. Then, the solution which melt | dissolved 62.9 g of H-His-OH * HCl and 28.0 mL of triethylamine (TEA) in 400 mL of water was added to this. It stirred for 1 hour at 0 degreeC and overnight at room temperature, and concentrated under reduced pressure. The remaining aqueous solution was washed with ethyl acetate and the aqueous layer was extracted with n-butanol. After washing several times with water, the n-butanol layer was concentrated under reduced pressure, solidified with ether, dissolved in water and adjusted to pH 5. The aqueous solution was poured into a column (5.0 × 20 cm) filled with HP-20, washed with water until the Pauli reaction of the effluent reached ±, and then eluted with methanol. The eluted methanol was concentrated under reduced pressure and the residue was treated with ether. Subsequently, it was recrystallized from methanol ether. Thus, 59.5 g (yield 74.3%) of Z-pGlu-His-OH were obtained.

Z-pGlu-His-OH의 융점, 선광도, TLC의 Rf 및 원소분석값을 하기에 나타내었다.The melting point of Z-pGlu-His-OH, photoluminescence, Rf of TLC and elemental analysis are shown below.

m.p. : 146∼149℃(분해)m.p. : 146-149 ° C (decomposition)

[α]D: -0.91(c=1.0, DMF)[α] D : -0.91 (c = 1.0, DMF)

Rf : 0.14(BuOH/AcOH/H2O=4/1/5)Rf: 0.14 (BuOH / AcOH / H 2 O = 4/1/5)

원소분석값(C19H20N4O6로서)Elemental Analysis Values (as C 19 H 20 N 4 O 6 )

이론값 C: 57.00% H: 5.03% N: 13.99%Theoretical C: 57.00% H: 5.03% N: 13.99%

측정값 C: 57.23% H: 5.05% N: 14.05%Found C: 57.23% H: 5.05% N: 14.05%

(1-8) Z-pGlu-His-Trp-OMe의 제조(1-8) Preparation of Z-pGlu-His-Trp-OMe

상기(1-7)로 제조한 Z-pGlu-His-OH 40.0g, H-Trp-OMe·HCl 19.6g 및 HOSu 12.7g을 DMF 100mL에 용해시켰다. 계속해서, 이 용액을 냉각시키면서 N-메틸모르폴린으로 중화시킨 후, WSC 2.0mL를 첨가하여 0℃에서 5분간, 실온에서 하룻밤 교반하였다. 닌히드린으로 확인 후, 반응혼합액을 감압농축하고, 잔사에 에틸아세테이트-n-부탄올(1:1) 200mL를 첨가하여 유기층을 물 100mL로 3회 세척하였다. 유기층을 감압농축하고 잔사를 에테르로 처리하여 고체화시켰다. 이와 같이 하여 Z-pGlu-His-Trp-OMe 48.5g(수율 92.3%)가 얻어졌다.40.0 g of Z-pGlu-His-OH, 19.6 g of H-Trp-OMe-HCl and 12.7 g of HOSu prepared in (1-7) were dissolved in 100 mL of DMF. Subsequently, after neutralizing with N-methylmorpholine while cooling this solution, 2.0 mL of WSC was added, and it stirred at 0 degreeC for 5 minutes, and overnight at room temperature. After confirming with ninhydrin, the reaction mixture was concentrated under reduced pressure, 200 mL of ethyl acetate-n-butanol (1: 1) was added to the residue, and the organic layer was washed three times with 100 mL of water. The organic layer was concentrated under reduced pressure and the residue was treated with ether to solidify. Thus, 48.5 g (yield 92.3%) of Z-pGlu-His-Trp-OMe was obtained.

Z-pGlu-His-Trp-OMe의 융점, 선광도, TLC의 Rf 및 원소분석값을 하기에 나타내었다.The melting point of Z-pGlu-His-Trp-OMe, photoluminescence, Rf of TLC and elemental analysis values are shown below.

m.p. : 112∼115℃(분해)m.p. : 112 to 115 ° C (decomposition)

[α]D: -1.5(c=1.0, DMF)[a] D : -1.5 (c = 1.0, DMF)

Rf : 0.3(BuOH/AcOH/H2O=4/1/5)Rf: 0.3 (BuOH / AcOH / H 2 O = 4/1/5)

원소분석값(C31H32N6O7S로서)Elemental Analysis Values (as C 31 H 32 N 6 O 7 S)

이론값 C: 61.99% H: 5.37% N: 13.99%Theoretical C: 61.99% H: 5.37% N: 13.99%

측정값 C: 61.54% H: 5.33% N: 13.80%Measured value C: 61.54% H: 5.33% N: 13.80%

(1-9) pGlu-His-Trp-OMe의 제조(1-9) Preparation of pGlu-His-Trp-OMe

상기(1-8)로 제조한 Z-pGlu-His-Trp-OMe 40.0g을 DMF 50mL에 용해시켜, 10% 팔라디움/탄소 500mg의 존재하에서 수소를 첨가하였다. 7시간 실온에서 교반한 후, 촉매를 제거하여 감압농축하고 잔사를 에테르로 처리하여 고체화하였다. 이와 같이 하여 pGlu-His-Trp-OMe 28.5g(수율 91.8%)가 얻어졌다.40.0 g of Z-pGlu-His-Trp-OMe prepared in (1-8) was dissolved in 50 mL of DMF, and hydrogen was added in the presence of 500 mg of 10% palladium / carbon. After stirring for 7 hours at room temperature, the catalyst was removed, concentrated under reduced pressure, and the residue was solidified by treating with ether. Thus, 28.5 g (yield 91.8%) of pGlu-His-Trp-OMe were obtained.

pGlu-His-Trp-OMe의 융점, 선광도, TLC의 Rf 및 원소분석값을 하기에 나타내었다.The melting point of pGlu-His-Trp-OMe, photoluminescence, Rf of TLC and elemental analysis are shown below.

m.p. : 132∼137℃(분석)m.p. : 132-137 degreeC (analysis)

[α]D: +4.1(c=1.0, DMF)[α] D : +4.1 (c = 1.0, DMF)

Rf : 0.18(BuOH/AcOH/H2O=4/1/5)Rf: 0.18 (BuOH / AcOH / H 2 O = 4/1/5)

원소분석값(C23H26N6O5로서)Elemental Analysis Values (as C 23 H 26 N 6 O 5 )

이론값 C: 59.22% H: 5.62% N: 18.02%Theoretical C: 59.22% H: 5.62% N: 18.02%

측정값 C: 59.01% H: 5.55% N: 17.89%Found C: 59.01% H: 5.55% N: 17.89%

(1-10) H-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt의 제조(1-10) Preparation of H-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-NHEt

상기(1-6)으로 제조한 Z-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt 93.0g을 메탄올 800mL에 용해시키고, 10% 팔라디움/탄소 5.0g의 존재하에서 수소를 첨가하였다. 7시간 실온에서 교반한 후, 촉매를 제거하여 감압농축하고 잔사를 에테르로 처리하여 고체화하였다. 이와 같이 하여 H-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt 74.0g(수율 90.3%)가 얻어졌다.93.0 g of Z-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-NHEt prepared in (1-6) was dissolved in 800 mL of methanol, and hydrogen was added in the presence of 5.0 g of 10% palladium / carbon. Added. After stirring for 7 hours at room temperature, the catalyst was removed, concentrated under reduced pressure, and the residue was solidified by treating with ether. Thus, 74.0 g of H-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-NHEt (yield 90.3%) was obtained.

H-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt의 융점, 선광도, TLC의 Rf 및 원소분석값을 하기에 나타내었다.Melting points, optical fluorescence, Rf of TLC and elemental analysis of H-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-NHEt are shown below.

m.p. : 124∼128℃(분해)m.p. : 124-128 degreeC (decomposition)

[α]D: +10.1(c=1.0, DMF)[α] D : +10.1 (c = 1.0, DMF)

Rf : 0.16(BuOH/AcOH/H2O=4/1/5)Rf: 0.16 (BuOH / AcOH / H 2 O = 4/1/5)

원소분석값(C38H64N10O9로서)Elemental Analysis Values (as C 38 H 64 N 10 O 9 )

이론값 C: 56.70% H: 8.01% N: 17.40%Theoretical C: 56.70% H: 8.01% N: 17.40%

측정값 C: 55.55% H: 7.97% N: 17.18%Found C: 55.55% H: 7.97% N: 17.18%

(1-11) pGlu-His-Trp-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt의 제조(1-11) Preparation of pGlu-His-Trp-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-NHEt

상기(1-9)로 제조한 pGlu-His-Trp-OMe 30g 및 상기(1-10)으로 제조한 H-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt 22g을 n-부탄올포화수 1,300mL에 용해시켰다. 1M의 염산 또는 암모니아수를 이용하여 pH 7.8로 조정하고, 그 용액에 1,000U/mg의 키모트립신 78mg을 n-부탄올포화수 2.5mL에 용해시킨 용액을 첨가하여 10℃에서 1시간 교반하였다. 반응혼합액에 n-부탄올 300mL를 첨가하고 합성된 펩티드를 물과 n-부탄올로 분배하여, 하층(수층)과 상층(n-부탄올층)으로 분리하였다. 하층에 n-부탄올(200mL)을 첨가하여 동일한 분배 크로마토그래피를 다시 3회 반복하였다. 상층은 물 100mL로 5회 세척하고, 유기층 및 수층을 각각 농축하여 각각을 에테르로 고체화하였다. 수층에서 회수한 H-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt는 재반응에 사용하였다. 유기층(n-부탄올)을 농축하고 잔사에 에테르를 첨가하여 분말화하였다.PGlu-His-Trp-OMe 30g prepared in (1-9) and H-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-NHEt 22g prepared in (1-10) were n It was dissolved in 1,300 mL of butanol saturated water. The pH was adjusted to 7.8 using 1 M hydrochloric acid or ammonia water, and a solution of 78 mg of 1,000 U / mg chymotrypsin in 2.5 mL of n-butanol saturated water was added thereto, followed by stirring at 10 ° C for 1 hour. 300 mL of n-butanol was added to the reaction mixture, and the synthesized peptide was partitioned into water and n-butanol, and separated into a lower layer (aqueous layer) and an upper layer (n-butanol layer). The same partition chromatography was repeated three more times by adding n-butanol (200 mL) to the lower layer. The upper layer was washed five times with 100 mL of water, and the organic and aqueous layers were each concentrated to solidify each with ether. H-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-NHEt recovered from the aqueous layer was used for the reaction. The organic layer (n-butanol) was concentrated and powdered by adding ether to the residue.

유기층에서 얻어진 분말은 0.01M 초산암모늄 수용액에 용해시키고, CM-셀룰로스를 충진한 칼럼(4×30cm)에 적용하였다. 0.01M 초산암모늄 수용액(pH 4.4) 500mL 내지 0.1M 초산암모니움 수용액(pH 4.4) 500mL의 직선형농도구배용출(60mL/시간)을 행하고, 그 용출액을 10mL씩 분획채취하였다. 용출액을 고속액체 크로마토그래피에 의하여 분석하고, 목적분획을 모아 동결건조하였다. 이와 같이 하여 pGlu-His-Trp-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt 22.4g이 얻어졌다(수율 74.9%).The powder obtained in the organic layer was dissolved in an aqueous 0.01 M ammonium acetate solution and applied to a column (4 × 30 cm) filled with CM-cellulose. 500 mL of 0.01 M aqueous ammonium acetate solution (pH 4.4) to 500 mL of 0.1 M aqueous ammonium acetate solution (pH 4.4) was used for linear farming equipment dissolution (60 mL / hour), and the eluate was fractionated in 10 mL portions. The eluate was analyzed by high performance liquid chromatography, and the desired fractions were lyophilized. Thus, 22.4 g of pGlu-His-Trp-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-NHEt was obtained (yield 74.9%).

pGlu-His-Trp-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt의 선광도, 원소분석값 및 아미노산 분석값을 하기에 나타내었다.The photoluminescence, elemental analysis and amino acid analysis of pGlu-His-Trp-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-NHEt are shown below.

[α]D: -46.0(c=1.0, H2O)[α] D : -46.0 (c = 1.0, H 2 O)

원소분석값(C60H86N16O13·CH3COOH·2H2O로서)Elemental Analysis Values (as C 60 H 86 N 16 O 13 CH 3 COOH 2 H 2 O)

이론값 C: 55.76% H: 7.09% N: 16.78%Theoretical C: 55.76% H: 7.09% N: 16.78%

측정값 C: 55.60% H: 7.10% N: 16.79%Measured value C: 55.60% H: 7.10% N: 16.79%

아미노산 조성;Amino acid composition;

Ser 2.05(2), Glu 1.08(1), Pro 0.99(1), Leu 1.09(1), Tyr 0.92(1), His 0.93(1), Arg 1.06(1)Ser 2.05 (2), Glu 1.08 (1), Pro 0.99 (1), Leu 1.09 (1), Tyr 0.92 (1), His 0.93 (1), Arg 1.06 (1)

(1-12) 고정화효소에 의한 pGlu-His-Trp-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt의 합성(1-12) Synthesis of pGlu-His-Trp-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-NHEt by Immobilized Enzyme

(1) pGlu-His-Trp-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt의 합성(1) Synthesis of pGlu-His-Trp-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-NHEt

상기(1-9)로 제조한 pGlu-His-Trp-OMe 2.00g 및 상기(1-10)으로 제조한 H-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt 1.30g을 물 200mL에 용해시키고, 1M의 염산 또는 암모니아수를 이용하여 pH 7.8로 조정하였다. 이 용액에 2000U/g의 고정화 키모트립신(아가로스 운반체)을 2.5g을 첨가하여 현탁시키고 pH 7.8임을 확인한 후, 10℃에서 1시간 교반하였다. 반응액을 유리필터에 여과하여 고정화 키모트립신키모트립신였다.2.00 g of pGlu-His-Trp-OMe prepared in (1-9) and H-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-NHEt prepared in (1-10) above Was dissolved in 200 mL of water and adjusted to pH 7.8 with 1 M hydrochloric acid or ammonia water. To this solution was suspended by adding 2.5 g of immobilized chymotrypsin (agarose carrier) at 2000 U / g and confirming that the pH was 7.8, and stirred at 10 ° C for 1 hour. The reaction solution was filtered through a glass filter to immobilize chymotrypsin chymotrypsin.

여과액을 농축하고, CM-셀룰로스를 충진한 칼럼(4×30cm)에 적용하였다. 0.01M의 초산암모늄 수용액(pH 4.4) 500mL 내지 0.1M의 초산암모늄 수용액(pH 4.4) 500mL의 직선형농도구배용출(60mL/시간)을 행하고, 그 용출을 10mL씩 분획채취하였다. 용출액을 HPLC에 의하여 분석하고, 목적의 분획을 보아 동결건조하였다. 이렇게 하여 pGlu-His-Trp-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt 1.45g을 얻었다(수율 82.4%).The filtrate was concentrated and applied to a column packed with CM-cellulose (4 × 30 cm). 500 mL of 0.01 M aqueous ammonium acetate solution (pH 4.4) to 500 mL of 0.1 M aqueous ammonium acetate solution (pH 4.4) were evaporated (60 mL / hour), and the elution was fractionated by 10 mL. The eluate was analyzed by HPLC and the desired fractions were lyophilized. Thus, 1.45 g of pGlu-His-Trp-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-NHEt was obtained (yield 82.4%).

또한, 얻어진 화합물의 융점, 선광도, TLC의 Rf값 및 원소분석값은 실시예1의 (1-11)로 제조한 pGlu-His-Trp-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt의 것과 일치하였다.Further, the melting point, the optical intensity, the Rf value of TLC and the elemental analysis value of the obtained compound were pGlu-His-Trp-Ser-Tyr-D-Ser (But) -Leu- prepared in (1-11) of Example 1. It is consistent with that of Arg-Pro-NHEt.

(2) 기질특이성의 검토(2) Examination of substrate specificity

상기의 효소반응 조건에서 표 1에 나타내는 펩티드를 기질로서 반응을 행하여 반응개시 2시간 후에 생성된 펩티드를 HPLC로 분석하고, 각 피크의 면적으로부터 수율을 계산하였다.Under the above enzyme reaction conditions, the peptides shown in Table 1 were reacted as substrates, and peptides generated 2 hours after the start of the reaction were analyzed by HPLC, and yields were calculated from the area of each peak.

사용한 기질Substrate used 수율(%)yield(%) pGlu-His-Trp-OMe + H-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-NHEtpGlu-His-D-Trp-OMe + H-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-NHEtpGlu-D-His-Trp-OMe + H-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-NHEtpGlu-His-Trp-OMe + H-D-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-NHEtpGlu-His-Trp-OMe + H-Ser-Tyr-D-Ser (tBu) -Leu-Arg-Pro-NHEtpGlu-His-D-Trp-OMe + H-Ser-Tyr-D-Ser (tBu)- Leu-Arg-Pro-NHEtpGlu-D-His-Trp-OMe + H-Ser-Tyr-D-Ser (tBu) -Leu-Arg-Pro-NHEtpGlu-His-Trp-OMe + HD-Ser-Tyr-D -Ser (tBu) -Leu-Arg-Pro-NHEt 78.80.07.80.078.80.07.80.0

표 1에서 나타내듯이, 효소의 인식부위인 트립토판이 D-형인 기질을 사용한 경우에는 수율은 0%이고 반응은 전혀 진행되지 않음이 나타났다. 또한, 효소의 인식부위 N 말단측에 인접하는 히스티딘이 D-형인 기질을 사용한 경우에는 수율은 7.8%로 낮았으나, 생성물이 있음이 확인되었다. 효소의 결합부위인 세린이 D-형인 기질을 사용한 경우도 수율은 0%이고, 반응이 진행되지 않음이 확인되었다.As shown in Table 1, when tryptophan, an enzyme recognition site, uses a D-type substrate, the yield was 0% and the reaction did not proceed at all. In addition, when the histidine adjacent to the N-terminal side of the enzyme was used as a D-type substrate, the yield was low as 7.8%, but it was confirmed that there was a product. It was also confirmed that the yield was 0% even when serine, which is an enzyme binding site, using a D-type substrate, and the reaction did not proceed.

이상에서, 효소합성을 이용하면 효소의 기질특이성에 의하여 세린 및 히스티딘의 라세미화가 일어나기 어려우므로, 광학순도가 높은 제품을 얻을 수 있음이 확인되었다.In the above, it was confirmed that racemization of serine and histidine is unlikely to occur due to substrate specificity of the enzyme, and thus a product having high optical purity can be obtained.

실시예 2Example 2

본 실시예에 있어서, 실시예 1의 (1-1) 내지 (1-3)에 따라 제조한 Z-D-Ser(But)-Leu-Arg-Pro-NHEt를 하기(2-1) 내지 (2-3)에 따라 제조한 것을 제외하고는, 실시예 1과 같은 방법으로 pGlu-His-Trp-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt를 제조하였다.In the present Example, ZD-Ser (But) -Leu-Arg-Pro-NHEt prepared according to (1-1) to (1-3) of Example 1 is represented by the following (2-1) to (2- Except that prepared according to 3), pGlu-His-Trp-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-NHEt was prepared in the same manner as in Example 1.

(2-1) Z-Leu-Arg-NHNH2의 제조(2-1) Preparation of Z-Leu-Arg-NHNH 2

Z-Leu-OH 172.5g 및 H-Arg-OEt·2HCl 178.9g을 DMF/THF(1/1) 혼합용액 800mL에 용해시키고, 0℃에서 N-에틸모르폴린 143mL를 첨가하여 중화하였다. 계속해서 DCC 147.5mL를 첨가하여 0℃에서 5분간, 실온에서 15시간 교반하였다. 반응용액을 감압농축하고, 얻어진 잔사에 물 1,000mL를 첨가하여 에틸아세테이트 500mL로 2회 세척한 후, 수층을 n-부탄올 1,000mL로 3회 추출하였다. 얻어진 n-부탄올층을 감압농축함으로써 Z-Leu-Arg-OEt가 얻어졌다.172.5 g of Z-Leu-OH and 178.9 g of H-Arg-OEt.2HCl were dissolved in 800 mL of a mixed solution of DMF / THF (1/1), and neutralized by addition of 143 mL of N-ethylmorpholine at 0 ° C. Then, DCD 147.5 mL was added and stirred at 0 ° C. for 5 minutes and at room temperature for 15 hours. The reaction solution was concentrated under reduced pressure, 1,000 mL of water was added to the obtained residue, the mixture was washed twice with 500 mL of ethyl acetate, and the aqueous layer was extracted three times with 1,000 mL of n-butanol. Z-Leu-Arg-OEt was obtained by concentrating the obtained n-butanol layer under reduced pressure.

Z-Leu-Arg-OEt를 메탄올 500mL에 용해시키고, 빙냉하에서 NH2NH2·H2O 150mL를 첨가하여 실온에서 18시간 교반하였다. 반응액을 감압농축하여 얻어진 잔사에 물 500mL를 첨가하고, n-부탄올 1,000mL로 5회 추출하였다. 추출액을 물 500mL로 4회 세척한 후, 감압농축하였다. 얻어진 잔사를 에테르로 처리하여 고체화하고 건조시켰다. 이렇게 하여 Z-Leu-Arg-NHNH2209.7g(수율 74.1%)가 얻어졌다.Z-Leu-Arg-OEt was dissolved in 500 mL of methanol, 150 mL of NH 2 NH 2 · H 2 O was added under ice-cooling, and the mixture was stirred at room temperature for 18 hours. 500 mL of water was added to the residue obtained by concentrating a reaction liquid under reduced pressure, and it extracted 5 times with 1,000 mL of n-butanol. The extract was washed four times with 500 mL of water and then concentrated under reduced pressure. The obtained residue was treated with ether to solidify and dry. In this way a 209.7g (yield: 74.1%) Z-Leu-Arg -NHNH 2 was obtained.

Z-Leu-Arg-NHNH2의 융점, 선광도, TLC의 Rf값 및 원소분석값을 하기에 나타내었다.The melting point of Z-Leu-Arg-NHNH 2, the photoluminescence, the Rf value of TLC and the elemental analysis value are shown below.

m.p. : 105∼107℃m.p. : 105 ~ 107 ℃

[α]D: -30.6(c=1.0, MeOH)[α] D : -30.6 (c = 1.0, MeOH)

Rf : 0.60(BuOH/AcOH/H2O=4/1/5)Rf: 0.60 (BuOH / AcOH / H 2 O = 4/1/5)

원소분석값(C20H33N7O4로서)Elemental Analysis Values (as C 20 H 33 N 7 O 4 )

이론값 C: 55.61% H: 7.64% N: 22.51%Theoretical C: 55.61% H: 7.64% N: 22.51%

측정값 C: 55.84% H: 7.42% N: 22.41%Found C: 55.84% H: 7.42% N: 22.41%

(2-2) Z-Leu-Arg-Pro-NHEt의 제조(2-2) Preparation of Z-Leu-Arg-Pro-NHEt

상기(2-1)로 제조한 Z-Leu-Arg-NHNH2130.8g을 DMF 500mL에 용해시키고, 드라이아이스-에탄올로 -20℃로 냉각시켰다. 그 용액에 4N HCl-다이옥산 225mL 및 아이소아밀 나이트레이드 40.5mL를 첨가하여 아자이드 화합물로 하였다. 또한 트리에틸아민 126mL를 첨가하여 중화하였다. 그 혼합액을 H-Pro-NHEt 42.6g을 포함하는 DMF 200mL 용액으로 옮겨, -20℃에서 2시간, 4℃에서 16시간 교반한 후 농축하였다. 잔사에 물 800mL를 첨가하여 에틸아세테이트 400mL으로 2회 세척한 후, 수층을 n-부탄올 800mL로 3회 추출하고 다시 물 400mL로 세척하였다. 얻어진 n-부탄올층을 감압농축하고 얻어진 잔사를 에테르로 처리하여 고체화하고 건조시켰다. 이와 같이 하여 Z-Leu-Arg-Pro-NHEt 154.5g(수율 94.3%)가 얻어졌다.130.8 g of Z-Leu-Arg-NHNH 2 prepared in (2-1) was dissolved in 500 mL of DMF, and cooled to -20 ° C with dry ice-ethanol. 225 mL of 4N HCl-dioxane and 40.5 mL of isoamyl nitrate were added to the solution to obtain an azide compound. Furthermore, 126 mL of triethylamine was added and neutralized. The mixture was transferred to a 200 mL solution of DMF containing 42.6 g of H-Pro-NHEt, stirred at -20 ° C for 2 hours, and at 4 ° C for 16 hours, and then concentrated. After adding 800 mL of water to the residue and washing twice with 400 mL of ethyl acetate, the aqueous layer was extracted three times with 800 mL of n-butanol and washed with 400 mL of water again. The obtained n-butanol layer was concentrated under reduced pressure, and the obtained residue was treated with ether to solidify and dried. In this manner, 154.5 g (yield 94.3%) of Z-Leu-Arg-Pro-NHEt was obtained.

Z-Leu-Arg-Pro-NHEt의 융점, 선광도, TLC의 Rf 및 원소분석값을 하기에 나타내었다.The melting point of Z-Leu-Arg-Pro-NHEt, photoluminescence, Rf of TLC, and elemental analysis values are shown below.

m.p. : 125∼126℃m.p. 125 to 126 ° C

[α]D: -66.6(c=1.0, MeOH)[α] D : -66.6 (c = 1.0, MeOH)

Rf : 0.45(BuOH/AcOH/H2O=4/1/5)Rf: 0.45 (BuOH / AcOH / H 2 O = 4/1/5)

원소분석값(C27H43N7O5로서)Elemental Analysis Values (as C 27 H 43 N 7 O 5 )

이론값 C: 59.43% H: 7.94% N: 17.97%Theoretical C: 59.43% H: 7.94% N: 17.97%

측정값 C: 59.31% H: 7.78% N: 18.13%Found C: 59.31% H: 7.78% N: 18.13%

(2-3) Z-D-Ser(But)-Leu-Arg-Pro-NHEt의 제조(2-3) Preparation of Z-D-Ser (But) -Leu-Arg-Pro-NHEt

상기(2-2)로 제조한 Z-Leu-Arg-NHEt 154.5g을 메탄올 1,500mL에 용해시키고, 10% 팔라디움/탄소 14g의 존재하에서 수소를 첨가하였다. 16시간 실온에서 교반한 후, 촉매를 제거하여 감압농축하여 H-Leu-Arg-Pro-NHEt가 얻어졌다.154.5 g of Z-Leu-Arg-NHEt prepared in (2-2) was dissolved in 1,500 mL of methanol, and hydrogen was added in the presence of 14 g of 10% palladium / carbon. After stirring at room temperature for 16 hours, the catalyst was removed and concentrated under reduced pressure to obtain H-Leu-Arg-Pro-NHEt.

Z-D-Ser(But)-OH 82.3g을 THF 200mL에 용해시키고, 드라이아이스-에탄올로 -20℃로 냉각하여 N-메틸모르폴린 30.7mL를 적하하고, 계속해서 이소부틸클로로포메이트 36.3mL 적하한 후, -20℃에서 1분간 교반하여 해당하는 혼합산무수물을 제조하였다. 얻어진 반응액을 H-Leu-Arg-Pro-NHEt을 포함하는 DMF 700mL 용액과 혼합하여 0℃에서 5분간, 실온에서 30분간 교반하였다. 그 후, 감압농축하고 잔사에 물 1,000mL를 첨가하여 에틸아세테이트 500mL로 2회 세척한 후, 수층을 에틸아세테이트/n-부탄올(2/1) 혼합용액 1,000mL로 2회 추출하였다. 추출액을 물 500mL로 5회 세척한 후, 감압농축하여 얻어진 잔사를 에테르로 처리하여 고체화하고 건조시켰다. 이와 같이 하여 D-Ser-(But)-Leu-Arg-Pro-NHEt 178.3g(수율 91.2%)가 얻어졌다.82.3 g of ZD-Ser (But) -OH was dissolved in 200 mL of THF, cooled to −20 ° C. with dry ice-ethanol, 30.7 mL of N-methylmorpholine was added dropwise, and then 36.3 mL of isobutylchloroformate was added dropwise. Then, the mixture was stirred for 1 minute at -20 ° C to prepare a corresponding mixed acid anhydride. The obtained reaction solution was mixed with a 700 mL solution of DMF containing H-Leu-Arg-Pro-NHEt and stirred at 0 ° C. for 5 minutes and at room temperature for 30 minutes. Thereafter, the mixture was concentrated under reduced pressure, 1,000 mL of water was added to the residue, the mixture was washed twice with 500 mL of ethyl acetate, and the aqueous layer was extracted twice with 1,000 mL of an ethyl acetate / n-butanol (2/1) mixed solution. The extract was washed 5 times with 500 mL of water, and the residue obtained by concentration under reduced pressure was treated with ether to solidify and dried. Thus, 178.3 g (yield 91.2%) of D-Ser- (But) -Leu-Arg-Pro-NHEt was obtained.

또한, 얻어진 화합물의 융점, 선광도, TLC의 Rf 및 원소분석값은 실시예 1의 (1-3)으로 제조한 D-Ser(But)-Leu-Arg-Pro-NHEt의 것과 일치하였다.In addition, melting | fusing point of the obtained compound, luminous intensity, Rf of TLC, and elemental analysis value were the same as that of D-Ser (But) -Leu-Arg-Pro-NHEt manufactured by (1-3) of Example 1.

실시예 3: pGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt의 제조Example 3: Preparation of pGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt

(3-1) Boc-D-Leu-Leu-Arg(Tos)-Pro-NHEt의 제조(3-1) Preparation of Boc-D-Leu-Leu-Arg (Tos) -Pro-NHEt

실시예 1의 (1-2)로 제조한 Z-Leu-Arg(Tos)-Pro-NHEt 20.99g을 메탄올 200mL에 용해시키, 10% 팔라디움/탄소 1.5g의 존재하에서 수소를 첨가하였다. 7시간 실온에서 교반한 후, 촉매를 제거하여 감압농축하여 잔사를 에테르로 처리하여 고체화하였다. 이렇게 하여 H--Leu-Arg(Tos)-Pro-NHEt를 얻었다.20.99 g of Z-Leu-Arg (Tos) -Pro-NHEt prepared in (1-2) of Example 1 was dissolved in 200 mL of methanol, and hydrogen was added in the presence of 10 g of palladium / 1.5 g of carbon. After stirring for 7 hours at room temperature, the catalyst was removed, concentrated under reduced pressure, and the residue was treated with ether to solidify. Thus, H-Leu-Arg (Tos) -Pro-NHEt was obtained.

H-Leu-Arg(Tos)-Pro-NHEt를 DMF 80mL 및 THF 200mL에 용해시키, 이 용액을 냉각시키면서 N-메틸모르폴린으로 중화시켰다. 계속해서, 이 용액에 Boc-D-Leu-OH 8.86g과 HOSu 23.02g을 THF 200mL에 용해시킨 용액 및 WSC 36.4mL를 첨가하여 0℃에서 5분간, 실온에서 하룻밤 교반하였다. 닌히드린으로 확인후, 반응혼합액을 감압농축하였다. 잔사에 물 500mL을 첨가하여 n-부탄올 200mL로 5회 추출하였다. 물로 5회 세척한 후, n-부탄올층을 감압농축하고 잔사를 에테르로 처리하여 고체화하였다. 이렇게 하여 Boc-D-Leu-Leu-Arg(Tos)-Pro-NHEt 21.5g(수율 92.1%)가 얻어졌다.H-Leu-Arg (Tos) -Pro-NHEt was dissolved in 80 mL DMF and 200 mL THF and neutralized with N-methylmorpholine while cooling the solution. Subsequently, a solution obtained by dissolving 8.86 g of Boc-D-Leu-OH and 23.02 g of HOSu in 200 mL of THF and 36.4 mL of WSC were added thereto, and the mixture was stirred at 0 ° C. for 5 minutes at room temperature overnight. After confirming with ninhydrin, the reaction mixture was concentrated under reduced pressure. 500 mL of water was added to the residue, and extracted with 200 mL of n-butanol five times. After washing five times with water, the n-butanol layer was concentrated under reduced pressure and the residue was treated with ether to solidify. Thus, 21.5 g of Boc-D-Leu-Leu-Arg (Tos) -Pro-NHEt (yield 92.1%) was obtained.

Boc-D-Leu-Leu-Arg(Tos)-Pro-NHEt의 융점, 선광도, TLC의 Rf 및 원소분석값을 하기에 나타내었다.The melting point of Boc-D-Leu-Leu-Arg (Tos) -Pro-NHEt, the photoluminescence, the Rf of TLC and the elemental analysis values are shown below.

m.p. : 119∼121℃m.p. : 119 ~ 121 ℃

[α]D: -45.2(c=1.0, MeOH)[α] D : -45.2 (c = 1.0, MeOH)

Rf : 0.50(BuOH/AcOH/H2O=4/1/5)Rf: 0.50 (BuOH / AcOH / H 2 O = 4/1/5)

원소분석값(C30H56N8O6로서)Elemental Analysis Values (as C 30 H 56 N 8 O 6 )

이론값 C: 57.67% H: 9.03% N: 17.93%Theoretical C: 57.67% H: 9.03% N: 17.93%

측정값 C: 57.43% H: 8.89% N: 17.80%Found C: 57.43% H: 8.89% N: 17.80%

(3-2) Z-Ser-Tyr-D-Leu-Leu-Arg(Tos)-Pro-NHEt의 제조(3-2) Preparation of Z-Ser-Tyr-D-Leu-Leu-Arg (Tos) -Pro-NHEt

상기(3-1)로 제조한 Boc-D-Leu-Leu-Arg(Tos)-Pro-NHEt 25.8g을 DCM 10mL에 용해시켰다. 빙냉하에서 TFA 10mL를 첨가하여 30분간 실온에서 교반하였다. 계속해서 감압농축하고, 잔사에 에테르 200mL를 첨가하여 고체화하고 건조시켰다. 이와 같이 하여 H-D-Leu-Leu-Arg(Tos)-Pro-NHEt·TFA를 얻었다.25.8 g of Boc-D-Leu-Leu-Arg (Tos) -Pro-NHEt prepared in (3-1) was dissolved in 10 mL of DCM. 10 mL of TFA was added under ice cooling, and the mixture was stirred at room temperature for 30 minutes. Then, the mixture was concentrated under reduced pressure, and 200 mL of ether was added to the residue to solidify and dry. Thus, H-D-Leu-Leu-Arg (Tos) -Pro-NHEt TFA was obtained.

Z-Ser-Tyr-NHNH216.6g을 DMF 100mL에 용해시키고, 드라이아이스-에탄올로 -20℃로 냉각시켰다. 그 용액에 4N HCl-다이옥산 29.8mL 및 아이소아밀 나이트레이드 5.3mL를 첨가하여 아자이드 화합물로 하였다. 또한 트리에틸아민 16.7mL를 첨가하여 중화한 혼합액을 H-D-Leu-Leu-Arg(Tos)-Pro-NHEt·TFA를 포함하는 DMF 200mL 용액으로 옮겨, -20℃에서 2시간, 4℃에서 17시간 교반한 후 농축하였다. 잔사에 물 500mL를 첨가하여 n-부탄올 200mL로 5회 추출하였다. 물로 5회 세척한 후, n-부탄올층을 감압농축하고 잔사를 에테르로 처리하여 고체화였다. 이와 같이 하여 Z-Ser-Tyr-D-Leu-Leu-Arg(Tos)-Pro-NHEt 25.0g(수율 83.2%)가 얻어졌다.16.6 g of Z-Ser-Tyr-NHNH 2 was dissolved in 100 mL of DMF and cooled to −20 ° C. with dry ice-ethanol. 29.8 mL of 4N HCl-dioxane and 5.3 mL of isoamyl nitrate were added to the solution to obtain an azide compound. In addition, 16.7 mL of triethylamine was added to the mixture, which was neutralized, and then transferred to a 200 mL solution of DMF containing HD-Leu-Leu-Arg (Tos) -Pro-NHEtTFA, followed by 2 hours at -20 ° C and 17 hours at 4 ° C. After stirring, it was concentrated. 500 mL of water was added to the residue, and extracted with 200 mL of n-butanol five times. After washing five times with water, the n-butanol layer was concentrated under reduced pressure and the residue was treated with ether to solidify. Thus, 25.0 g of Z-Ser-Tyr-D-Leu-Leu-Arg (Tos) -Pro-NHEt (yield 83.2%) was obtained.

Z-Ser-Tyr-D-Leu-Leu-Arg(Tos)-Pro-NHEt의 융점, 선광도, TLC의 Rf 및 원소분석값을 하기에 나타내었다.The melting point of Z-Ser-Tyr-D-Leu-Leu-Arg (Tos) -Pro-NHEt, the photoluminescence, Rf of TLC, and elemental analysis values are shown below.

m.p. : 114∼118℃(분해)m.p. : 114 to 118 ° C (decomposition)

[α]D: -30.1(c=1.0, DMF)[α] D : -30.1 (c = 1.0, DMF)

Rf : 0.32(BuOH/AcOH/H2O=4/1/5)Rf: 0.32 (BuOH / AcOH / H 2 O = 4/1/5)

원소분석값(C45H68N10O10로서)Elemental Analysis Values (as C 45 H 68 N 10 O 10 )

이론값 C: 59.45% H: 7.54% N: 15.41%Theoretical C: 59.45% H: 7.54% N: 15.41%

측정값 C: 59.33% H: 7.52% N: 15.32%Measured value C: 59.33% H: 7.52% N: 15.32%

(3-3) H-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt의 제조(3-3) Preparation of H-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt

상기(3-2)로 제조한 Z-Ser-Tyr-D-Leu-Leu-Arg(Tos)-Pro-NHEt 20.4g에 아니솔 32mL를 첨가하고, 드라이아이스-에탄올로 -70℃로 냉각시켰다. 여기에 HF 200mL를 첨가하여 0℃에서 1시간 교반하였다. 그 후, 감압농축하여 잔사를 에테르로 처리하고 석출한 생성물을 여과하고, 수산화나트륨상에서 진공건조하였다. 이렇게 하여 H-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt 16.0g(수율 92.4%)가 얻어졌다.32 mL of anisole was added to 20.4 g of Z-Ser-Tyr-D-Leu-Leu-Arg (Tos) -Pro-NHEt prepared in (3-2) above, and cooled to -70 ° C with dry ice-ethanol. . HF 200mL was added here and it stirred at 0 degreeC for 1 hour. Thereafter, the mixture was concentrated under reduced pressure, the residue was treated with ether, and the precipitated product was filtered and dried in vacuo over sodium hydroxide. Thus, 16.0 g (yield 92.4%) of H-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt was obtained.

H-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt의 융점, 선광도, TLC의 Rf 및 원소분석값을 하기에 나타내었다.The melting point of H-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt, the photoluminescence, Rf of TLC, and elemental analysis values are shown below.

m.p. : 121∼123℃m.p. : 121 ~ 123 ℃

[α]D: +11.0(c=1.0, DMF)[α] D : +11.0 (c = 1.0, DMF)

Rf : 0.20(BuOH/AcOH/H2O=4/1/5)Rf: 0.20 (BuOH / AcOH / H 2 O = 4/1/5)

원소분석값(C37H62N10O8로서)Elemental Analysis Values (as C 37 H 62 N 10 O 8 )

이론값 C: 57.35% H: 8.06% N: 18.07%Theoretical C: 57.35% H: 8.06% N: 18.07%

측정값 C: 57.21% H: 8.01% N: 18.10%Found C: 57.21% H: 8.01% N: 18.10%

(3-4) pGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt의 제조(3-4) Preparation of pGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt

H-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt 대신에, 상기(3-3)으로 제조한 H-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt 1.30g을 이용한 것을 제외하고는, 실시예 1의 (1-11)과 같은 방법에 의하여 pGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt 1.33g을 얻었다(수율 76.4%).Instead of H-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-NHEt, H-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt 1.30 prepared above (3-3) Except for using g, 1.33 g of pGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt was obtained by the same method as in (1-11) of Example 1 (yield 76.4 %).

pGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt의 선광도, 원소분석값 및 아미노산 분석값을 하기에 나타내었다.The photoluminescence, elemental analysis and amino acid analysis of pGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt are shown below.

[α]D: -32.0(c=0.52, 5% AcOH)[a] D : -32.0 (c = 0.52, 5% AcOH)

원소분석값(C59H84N16O12로서)Elemental Analysis Values (as C 59 H 84 N 16 O 12 )

이론값 C: 58.59% H: 7.00% N: 18.53%Theoretical C: 58.59% H: 7.00% N: 18.53%

측정값 C: 58.40% H: 7.10% N: 18.31%Found: C: 58.40% H: 7.10% N: 18.31%

아미노산 조성Amino acid composition

Ser 1.05(1), Glu 1.08(1), Pro 0.99(1), Leu 2.09(2), Tyr 0.92(1), His 0.93(1), Arg 1.06(1)Ser 1.05 (1), Glu 1.08 (1), Pro 0.99 (1), Leu 2.09 (2), Tyr 0.92 (1), His 0.93 (1), Arg 1.06 (1)

실시예 4: pGlu-His-Trp-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-Azgly-NH2의 제조Example 4 Preparation of pGlu-His-Trp-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-Azgly-NH 2

(4-1) Z-Pro-Azgly-NH2의 제조(4-1) Preparation of Z-Pro-Azgly-NH 2

Z-Pro-OH 24.9g, 세미카바자이드염산염 11.2g 및 트리에틸아민 14.5g을 DMF 200mL에 용해시켰다. 그 용액에 0℃로 냉각하고 DCC 20.6g을 첨가하여, 4℃에서 16시간 교반하였다. 그 후, 반응혼합액으로부터 디시클로헥실우레아(DCU)를 여과하여 제거하고 감압농축하였다. 잔사에 에틸아세테이트 500mL를 첨가하고 물 200mL로 2회 세척하였다. 감압농축하고 잔사를 에테르로 처리하여 고체화하였다. 이렇게 하여 Z-Pro-Azgly-NH2의 16.7g(수율 54.3%)가 얻어졌다.24.9 g of Z-Pro-OH, 11.2 g of semicarbazide hydrochloride and 14.5 g of triethylamine were dissolved in 200 mL of DMF. It cooled to 0 degreeC, the DCC20.6g was added, and it stirred at 4 degreeC for 16 hours. Thereafter, dicyclohexylurea (DCU) was removed from the reaction mixture by filtration and concentrated under reduced pressure. 500 mL of ethyl acetate was added to the residue, and the mixture was washed twice with 200 mL of water. Concentrated under reduced pressure and the residue was treated with ether to solidify. Thus, 16.7 g (yield 54.3%) of Z-Pro-Azgly-NH 2 were obtained.

Z-Pro-Azgly-NH2의 융점, 선광도, TLC의 Rf 및 원소분석값을 하기에 나타내었다.The melting point of Z-Pro-Azgly-NH 2, the photoluminescence, the Rf of TLC and the elemental analysis values are shown below.

m.p. : 189∼190℃m.p. : 189 ~ 190 ℃

[α]D: -43.6(c=1.4, DMF)[α] D : -43.6 (c = 1.4, DMF)

Rf : 0.62(BuOH/AcOH/H2O=4/1/5)Rf: 0.62 (BuOH / AcOH / H 2 O = 4/1/5)

원소분석값(C14H18N4O4로서)Elemental Analysis Values (as C 14 H 18 N 4 O 4 )

이론값 C: 54.89% H: 5.95% N: 18.29%Theoretical C: 54.89% H: 5.95% N: 18.29%

측정값 C: 54.41% H: 7.74% N: 15.60%Measured value C: 54.41% H: 7.74% N: 15.60%

(4-2) Boc-Arg(NO2)-Pro-Azgly-NH2의 제조(4-2) Preparation of Boc-Arg (NO 2 ) -Pro-Azgly-NH 2

상기(4-1)로 제조한 Z-Pro-Azgly-NH216.5g을 DMF 500mL에 용해시키고, 10% 팔라디움/탄소 1.1g의 존재하에서 수소를 첨가하였다. 7시간 실온에서 교반한 후, 촉매를 제거하여 감압농축하였다. 잔사에 에테르 1,500mL를 첨가하여, 고체화하고 건조시켰다. 이렇게 하여 H-Pro-Azgly-NH2·TFA를 얻었다.16.5 g of Z-Pro-Azgly-NH 2 prepared in (4-1) was dissolved in 500 mL of DMF, and hydrogen was added in the presence of 1.1 g of 10% palladium / carbon. After stirring for 7 hours at room temperature, the catalyst was removed and concentrated under reduced pressure. 1,500 mL of ether was added to the residue, solidified and dried. Thus, H-Pro-Azgly-NH 2 · TFA was obtained.

Boc-Arg(NO2)-OH 13.5g을 THF 100mL에 용해시키고, 드라이아이스-에탄올로 -20℃로 냉각시켜 N-메틸모르폴린 3.3mL를 적하하고, 계속해서 이소부틸클로로포메이트 3.96mL를 적하한 후, -20℃에서 1분간 교반하여 해당하는 혼합산무수물을 제조하였다. 얻어진 반응액을 H-Pro-Azgly-NH2·TFA의 DMF 용액(N-메틸모르폴린으로 중화한 것) 200mL와 혼합하여 0℃에서 5분간, 실온에서 30분간 교반한 후 감압농축하였다. 잔사에 물 500mL를 첨가하여 n-부탄올 200mL로 5회 추출하였다. 물로 5회 세척한 후, n-부탄올층을 감압농축하고 잔사를 에테르로 처리하여 고체화하였다. 이와 같이 하여 Boc-Arg(NO2)-Pro-Azgly-NH216.7g(수율 88.6%)가 얻어졌다.13.5 g of Boc-Arg (NO 2 ) -OH was dissolved in 100 mL of THF, cooled to −20 ° C. with dry ice-ethanol, and 3.3 mL of N-methylmorpholine was added dropwise, followed by 3.96 mL of isobutylchloroformate. After dropping, the mixture was stirred for 1 minute at -20 ° C to prepare a corresponding mixed acid anhydride. The obtained reaction solution was mixed with 200 mL of a DMF solution (neutralized with N-methylmorpholine) of H-Pro-Azgly-NH 2 · TFA, stirred at 0 ° C. for 5 minutes, at room temperature for 30 minutes, and then concentrated under reduced pressure. 500 mL of water was added to the residue, and extracted with 200 mL of n-butanol five times. After washing five times with water, the n-butanol layer was concentrated under reduced pressure and the residue was treated with ether to solidify. In this manner, the Boc-Arg (NO 2) -Pro -Azgly-NH 2 16.7g ( yield 88.6%) was obtained.

Boc-Arg(NO2)-Pro-Azgly-NH2의 융점, 선광도, TLC의 Rf 및 원소분석값을 하기에 나타내었다.Melting points, optical fluorescence, Rf of TLC and elemental analysis of Boc-Arg (NO 2 ) -Pro-Azgly-NH 2 are shown below.

m.p. : 135∼137℃(분해)m.p. : 135 to 137 ° C (decomposition)

[α]D: +35.3(c=1.0, DMF)[a] D : +35.3 (c = 1.0, DMF)

Rf : 0.49(BuOH/AcOH/H2O=4/1/5)Rf: 0.49 (BuOH / AcOH / H 2 O = 4/1/5)

원소분석값(C17H31N9O7로서)Elemental Analysis Values (as C 17 H 31 N 9 O 7 )

이론값 C: 43.12% H: 6.60% N: 26.62%Theoretical C: 43.12% H: 6.60% N: 26.62%

측정값 C: 54.41% H: 7.74% N: 15.60%Measured value C: 54.41% H: 7.74% N: 15.60%

(4-3) Z-Leu-Arg(NO2)-Pro-Azgly-NH2(서열번호 2)의 제조(4-3) Preparation of Z-Leu-Arg (NO 2 ) -Pro-Azgly-NH 2 (SEQ ID NO: 2)

상기(4-2)로 제조한 Boc-Arg-(NO2)-Pro-NHEt 110.54g을 DCM 150mL에 용해시켰다. 이 용액에, 빙냉하에서 TFA 150mL를 첨가하여 30분간 실온에서 교반하였다. 계속해서 그 반응혼합액을 감압농축하고, 잔사에 에테르 1,500mL를 첨가하여 고체화하고 건조시켰다. 이와 같이 하여 H-Arg(NO2)-Pro-NHEt·TFA를 얻었다.110.54 g of Boc-Arg- (NO 2 ) -Pro-NHEt prepared in (4-2) was dissolved in 150 mL of DCM. 150 mL of TFA was added to this solution under ice cooling, and it stirred at room temperature for 30 minutes. Subsequently, the reaction mixture was concentrated under reduced pressure, 1,500 mL of ether was added to the residue, solidified and dried. Thus, H-Arg (NO 2) -Pro-NHEt TFA was obtained.

H-Arg(NO2)-Pro-NHEt·TFA를 DMF 80mL 및 THF 200mL의 혼합용매에 용해시키고, 이 용액을 냉각시키면서 N-메틸모르폴린으로 중화시켰다. 계속해서 이 용액에, Z-Leu-OH 53.06g(0.2mole)과 HOSu 23.02g(0.22mole)을 THF 200mL에 용해시킨 용액 및 WSC 36.4mL를 첨가하여 0℃에서 5분간, 실온에서 하룻밤 교반하였다. 닌히드린으로 확인후, 반응혼합액을 감압농축하였다. 잔사에 에틸아세테이트 1,500mL를 첨가하고, 물 500mL로 2회, 포화식염수 500mL로 2회 세척하였다. 그 후 에틸아세테이트층을 감압농축하고, 잔사를 에테르로 처리하여 고체화하고 건조시켰다. 이와 같이 하여 Z-Leu-Arg(NO2)-Pro-Azgly-NH2(서열번호 2) 27.52g(수율 98.6%)가 얻어졌다.H-Arg (NO 2 ) -Pro-NHEt.TFA was dissolved in a mixed solvent of 80 mL of DMF and 200 mL of THF, and the solution was neutralized with N-methylmorpholine while cooling. Subsequently, a solution obtained by dissolving 53.06 g (0.2 mole) of Z-Leu-OH and 23.02 g (0.22 mole) of HOSu in THF 200 mL and 36.4 mL of WSC were added thereto, and the mixture was stirred at 0 ° C. for 5 minutes at room temperature overnight. . After confirming with ninhydrin, the reaction mixture was concentrated under reduced pressure. 1,500 mL of ethyl acetate was added to the residue, and washed twice with 500 mL of water and twice with 500 mL of saturated saline. The ethyl acetate layer was then concentrated under reduced pressure, and the residue was treated with ether to solidify and dry. Thus, 27.52 g (yield 98.6%) of Z-Leu-Arg (NO 2 ) -Pro-Azgly-NH 2 (SEQ ID NO: 2) was obtained.

Z-Leu-Arg(NO2)-Pro-Azgly-NH2의 융점, 선광도, TLC의 Rf 및 원소분석값을 하기에 나타내었다.The melting point of Z-Leu-Arg (NO 2 ) -Pro-Azgly-NH 2, the photoluminescence, the Rf of TLC and the elemental analysis values are shown below.

m.p. : 88∼90℃m.p. : 88 ~ 90 ℃

[α]D: -30.2(c=1.5, DMF)[a] D : -30.2 (c = 1.5, DMF)

Rf : 0.57(BuOH/AcOH/H2O=4/1/5)Rf: 0.57 (BuOH / AcOH / H 2 O = 4/1/5)

원소분석값(C26H40N10O8로서)Elemental Analysis Values (as C 26 H 40 N 10 O 8 )

이론값 C: 50.31% H: 6.50% N: 22.57%Theoretical C: 50.31% H: 6.50% N: 22.57%

측정값 C: 50.24% H: 6.41% N: 22.45%Measured value C: 50.24% H: 6.41% N: 22.45%

(4-4) Z-D-Ser(But)-Leu-Arg-Pro-Azgly-NH2의 제조(4-4) Preparation of ZD-Ser (But) -Leu-Arg-Pro-Azgly-NH 2

상기(4-3)으로 제조한 Z-Leu-Arg(NO2)-Pro-Azgly-NH2(서열번호 2) 16.5g을 DMF 500mL에 용해시키고, 10% 팔라디움/탄소 1.1g의 존재하에서 수소를 첨가하였다. 7시간 실온에서 교반한 후, 촉매를 제거하여 감압농축하였다. 잔사에 에테르 1,500mL를 첨가하여, 고체화하고 건조시켰다. 이렇게 하여 H-Leu-Arg-Pro-Azgly-NH2(서열번호 3)를 얻었다.16.5 g of Z-Leu-Arg (NO 2 ) -Pro-Azgly-NH 2 (SEQ ID NO: 2) prepared in (4-3) was dissolved in 500 mL of DMF, and hydrogen was present in the presence of 1.1 g of 10% palladium / carbon. Was added. After stirring for 7 hours at room temperature, the catalyst was removed and concentrated under reduced pressure. 1,500 mL of ether was added to the residue, solidified and dried. Thus, H-Leu-Arg-Pro-Azgly-NH 2 (SEQ ID NO: 3) was obtained.

Z-D-Ser(But)-OH 8.86g을 THF 100mL에 용해시키고, 드라이아이스-에탄올로 -20℃로 냉각시켜 N-메틸모르폴린 3.3mL를 적하하고, 계속해서 이소부틸클로로포메이트 3.96mL을 적하한 후, -20℃에서 1분간 교반하여 해당하는 혼합산무수물을 제조하였다. 얻어진 반응액을 H-Leu-Arg-Pro-Azgly-NH2를 포함하는 DMF 200mL 용액(N-메틸모르폴린으로 중화한 것)과 혼합하여 0℃에서 5분간, 실온에서 30분간 교반한 후 감압농축하였다. 잔사에 물 500mL를 첨가하여 n-부탄올 200mL로 5회 추출하였다. 물로 5회 세척한 후, n-부탄올층을 감압농축하고 잔사를 에테르로 처리하여 고체화하였다. 이와 같이 하여 Z-D-Ser(But)-Leu-Arg-Pro-Azgly-NH216.9g(수율 78.3%)가 얻어졌다.8.86 g of ZD-Ser (But) -OH was dissolved in 100 mL of THF, cooled to −20 ° C. with dry ice-ethanol, and 3.3 mL of N-methylmorpholine was added dropwise, followed by dropwise addition of 3.96 mL of isobutylchloroformate. After that, the mixture was stirred for 1 minute at -20 ° C to prepare a corresponding mixed acid anhydride. The reaction solution was mixed with a 200 mL solution of DMF containing H-Leu-Arg-Pro-Azgly-NH 2 (neutralized with N-methylmorpholine), stirred at 0 ° C. for 5 minutes, and at room temperature for 30 minutes, and then decompressed. Concentrated. 500 mL of water was added to the residue, and extracted with 200 mL of n-butanol five times. After washing five times with water, the n-butanol layer was concentrated under reduced pressure and the residue was treated with ether to solidify. Thus, 16.9 g of ZD-Ser (But) -Leu-Arg-Pro-Azgly-NH 2 (yield 78.3%) was obtained.

Z-D-Ser(But)-Leu-Arg-Pro-Azgly-NH2의 융점, 선광도, TLC의 Rf 및 원소분석값을 하기에 나타내었다.The melting point of ZD-Ser (But) -Leu-Arg-Pro-Azgly-NH 2, the photoluminescence, Rf of TLC, and elemental analysis values are shown below.

m.p. : 115∼118℃m.p. : 115 ~ 118 ℃

[α]D: -45.8(c=1.0, DMF)[α] D : -45.8 (c = 1.0, DMF)

Rf : 0.51(BuOH/AcOH/H2O=4/1/5)Rf: 0.51 (BuOH / AcOH / H 2 O = 4/1/5)

원소분석값(C33H54N10O8로서)Elemental Analysis Values (as C 33 H 54 N 10 O 8 )

이론값 C: 55.14% H: 7.57% N: 19.48%Theoretical C: 55.14% H: 7.57% N: 19.48%

측정값 C: 55.01% H: 7.42% N: 19.33%Found C: 55.01% H: 7.42% N: 19.33%

(4-5) Z-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-Azgly-NH2의 제조(4-5) Preparation of Z-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-Azgly-NH 2

상기(4-4)로 제조한 Z-D-Ser(But)-Leu-Arg-Pro-Azgly-NH226.7g을 메탄올 500mL에 용해시키고, 10% 팔라디움/탄소 1.9g의 존재하에서 수소를 첨가하였다. 7시간 실온에서 교반한 후, 촉매를 제거하여 감압농축하였다. 잔사에 에테르로 처리하고, 석출한 생성물을 여과하여 수산화나트륨상에서 진공건조시켰다. 이와 같이 하여 H-D-Ser(But)-Leu-Arg-Pro-Azgly-NH2를 얻었다.26.7 g of ZD-Ser (But) -Leu-Arg-Pro-Azgly-NH 2 prepared in (4-4) was dissolved in 500 mL of methanol, and hydrogen was added in the presence of 1.9 g of 10% palladium / carbon. After stirring for 7 hours at room temperature, the catalyst was removed and concentrated under reduced pressure. The residue was treated with ether and the precipitated product was filtered and dried in vacuo over sodium hydroxide. Thus, HD-Ser (But) -Leu-Arg-Pro-Azgly-NH 2 was obtained.

실시예 1의 (1-5)로 제조한 Z-Ser-Tyr-NHNH218.5g을 DMF 150mL에 용해시키고, 드라이아이스-에탄올로 -20℃로 냉각시켰다. 그 용액에 4N HCl-다이옥산 33.4mL 및 아이소아밀 나이트레이드 6.0mL를 첨가하여 아자이드 화합물로 하였다. 또한 트리에틸아민 18.7mL를 첨가하여 중화한 혼합액을 H-D-Ser(But)-Leu-Arg-Pro-Azgly-NH2를 포함하는 DMF 150mL 용액으로 옮겨, -20℃에서 2시간, 4℃에서 17시간 교반한 후 농축하였다. 잔사에 물 500mL를 첨가하여 n-부탄올 200mL로 5회 추출하였다. 물로 5회 세척한 후, n-부탄올층을 감압농축하고 잔사를 에테르로 처리하여 고체화하였다. 이와 같이 하여 Z-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-Azgly-NH228.3g(수율 78.6%)가 얻어졌다.18.5 g of Z-Ser-Tyr-NHNH 2 prepared in (1-5) of Example 1 was dissolved in 150 mL of DMF, and cooled to −20 ° C. with dry ice-ethanol. 33.4 mL of 4N HCl-dioxane and 6.0 mL of isoamyl nitrate were added to the solution to obtain an azide compound. In addition, 18.7 mL of triethylamine was added to the mixture, which was neutralized, and transferred to a 150 mL solution of DMF containing HD-Ser (But) -Leu-Arg-Pro-Azgly-NH 2 . After stirring for time, it was concentrated. 500 mL of water was added to the residue, and extracted with 200 mL of n-butanol five times. After washing five times with water, the n-butanol layer was concentrated under reduced pressure and the residue was treated with ether to solidify. Thus, 28.3 g (yield 78.6%) of Z-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-Azgly-NH 2 was obtained.

Z-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-Azgly-NH2의 융점, 선광도, TLC의 Rf 및 원소분석값을 하기에 나타내었다.The melting point, photoluminescence, Rf of TLC and elemental analysis of Z-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-Azgly-NH 2 are shown below.

m.p. : 110∼113℃(분해)m.p. : 110 to 113 ° C (decomposition)

[α]D: -28.2(c=1.0, DMF)[α] D : -28.2 (c = 1.0, DMF)

Rf : 0.36(BuOH/AcOH/H2O=4/1/5)Rf: 0.36 (BuOH / AcOH / H 2 O = 4/1/5)

원소분석값(C45H68N12O12로서)Elemental Analysis Values (as C 45 H 68 N 12 O 12 )

이론값 C: 55.77% H: 7.07% N: 17.34%Theoretical C: 55.77% H: 7.07% N: 17.34%

측정값 C: 55.64% H: 7.01% N: 17.29%Found C: 55.64% H: 7.01% N: 17.29%

(4-6) H-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-Azgly-NH2의 제조(4-6) Preparation of H-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-Azgly-NH 2

상기(4-5)로 제조한 Z-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-Azgly-NH225.4g을 메탄올 500mL에 용해시키고, 10% 팔라디움/탄소 1.3g의 존재하에서 수소를 첨가하였다. 7시간 실온에서 교반한 후, 촉매를 제거하여 감압농축하였다. 잔사를 에테르로 처리하여 고체화하였다. 이렇게 하여 H-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-Azgly-NH220.7g(수율 94.6%)이 얻어졌다.25.4 g of Z-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-Azgly-NH 2 prepared in (4-5) above was dissolved in 500 mL of methanol and 1.3 g of 10% palladium / carbon was present. Hydrogen was added under. After stirring for 7 hours at room temperature, the catalyst was removed and concentrated under reduced pressure. The residue was treated with ether to solidify. Thus, 20.7 g (yield 94.6%) of H-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-Azgly-NH 2 was obtained.

H-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-Azgly-NH2의 융점, 선광도, TLC의 Rf 및 원소분석값을 하기에 나타내었다.The melting point, linearity, Rf of TLC, and elemental analysis of H-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-Azgly-NH 2 are shown below.

m.p. : 120∼122℃m.p. : 120-122 degreeC

[α]D: +11.2(c=1.0, DMF)[a] D : +11.2 (c = 1.0, DMF)

Rf : 0.31(BuOH/AcOH/H2O=4/1/5)Rf: 0.31 (BuOH / AcOH / H 2 O = 4/1/5)

원소분석값(C37H62N12O10로서)Elemental Analysis Values (as C 37 H 62 N 12 O 10 )

이론값 C: 53.22% H: 7.48% N: 20.13%Theoretical C: 53.22% H: 7.48% N: 20.13%

측정값 C: 53.193% H: 7.43% N: 20.01%Found C: 53.193% H: 7.43% N: 20.01%

(4-7) pGlu-His-Trp-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-Azgly-NH2의 제조(4-7) Preparation of pGlu-His-Trp-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-Azgly-NH 2

H-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt 대신에, 상기(4-6)으로 제조한 H-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-Azgly-NH21.30g을 이용한 것을 제외하고는, 실시예 1의 (1-11)과 같은 방법에 의하여 pGlu-His-Trp-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-Azgly-NH21.29g(수율 75.9%)을 얻었다.Instead of H-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-NHEt, H-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro prepared as (4-6) above PGlu-His-Trp-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro by the same method as (1-11) of Example 1, except that 1.30 g of -Azgly-NH 2 was used. 1.29 g (Yield 75.9%) of -Azgly-NH 2 was obtained.

pGlu-His-Trp-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-Azgly-NH2의 융점, 선광도, TLC의 Rf 및 원소분석값을 하기에 나타내었다.The melting point of the pGlu-His-Trp-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-Azgly-NH 2, the photoluminescence, the Rf of the TLC and the elemental analysis values are shown below.

[α]D: -52.4(c=1.0, DMF)[α] D : -52.4 (c = 1.0, DMF)

원소분석값(C59H84N18O14로서)Elemental Analysis Values (as C 59 H 84 N 18 O 14 )

이론값 C: 55.82% H: 6.67% N: 19.86%Theoretical C: 55.82% H: 6.67% N: 19.86%

측정값 C: 55.70% H: 6.55% N: 19.72%Measured value C: 55.70% H: 6.55% N: 19.72%

아미노산 조성Amino acid composition

Ser 2.02(2), Glu 1.07(1), Pro 1.00(1), Leu 1.03(1), Tyr 0.92(1), His 0.94(1), Arg 1.02(1)Ser 2.02 (2), Glu 1.07 (1), Pro 1.00 (1), Leu 1.03 (1), Tyr 0.92 (1), His 0.94 (1), Arg 1.02 (1)

실시예 5: pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2의 제조Example 5: Preparation of pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH 2

(5-1) H-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2의 제조(5-1) Preparation of H-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH 2

고상합성장치로서 Milligen Bioresearch사의 펩티드합성기 9600을 이용하여 고상합성을 행하였다.Solid phase synthesis was performed using a peptide synthesizer 9600 manufactured by Milligen Bioresearch as a solid phase synthesis apparatus.

먼저, p-메틸벤즈히드릴아민(MBHA) 수지(펩티드연구사, 아미노기 0.72mmol/g) 694mg을 펩티드 고상합성용 반응용기에 가하고, DCM 8mL(4회, 각 1분간), 60% TFA 함유 DCM 용액 8mL(20분간), DCM 4mL(3회, 각 15초간), DIEA 1mL 함유 DMF 용액 3mL(2회, 각 1분간) DMF 8mL(6회, 각 40초간)의 순으로 아르곤가스 기류속에서 교반하여 처리하였다. 또한 각각의 처리마다 여과를 행하였다.First, 694 mg of p-methylbenzhydrylamine (MBHA) resin (Peptide Researcher, 0.72 mmol / g amino group) was added to a reaction vessel for peptide high phase synthesis, DCM 8 mL (4 times, 1 min each), DCM containing 60% TFA 8 mL of solution (20 minutes), 4 mL of DCM (3 times, 15 seconds each), 3 mL of DMF solution containing 1 mL of DIEA (2 times, 1 minute each) 8 mL of DMF (6 times, 40 seconds each) in the argon gas stream Agitation was performed. In addition, filtration was performed for each treatment.

한편, pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2의 아미노산 서열 제 10번째의 아미노산 잔기에 반응하는 Boc-Gly-OH 2mmol을 DCM 4mL에 용해시켰다. 이 용액을 아미노산 활성화 용기에 가하고, DCC(0.5M-DCM 용액) 3mL 및 HOBt(0.5M-DCM 용액) 4mL를 첨가하여 30분간 반응시켰다. 반응액을 여과하여 농축용기로 옮겼다. 이것에 DMF 3mL를 첨가하고, 아르곤가스 기류하에서 DCM을 증류하여 제거한 후, DMF 3mL를 첨가하여 전기의 펩티드 고상합성용 반응용기로 옮겨 30분간 반응시켰다. 계속해서 DCM 8mL로 세척하였다(6회, 각 20초간). 또한, Boc-Gly-OH 2mmol을 DCM 4mL에 용해시키고, 아미노산 활성화 반응용기속에서 동일한 조작을 반복하는 이른바 더블커플링법을 행한 후, 여과하여 Boc-Gly-MBHA 수지를 얻었다.On the other hand, 2 mmol of Boc-Gly-OH reacting with the 10th amino acid residue of the amino acid sequence of pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH 2 was dissolved in 4 mL of DCM. . This solution was added to the amino acid activation vessel, and 3 mL of DCC (0.5M-DCM solution) and 4 mL of HOBt (0.5M-DCM solution) were added to react for 30 minutes. The reaction solution was filtered and transferred to a concentration vessel. 3 mL of DMF was added thereto, DCM was distilled off under an argon gas stream, and then 3 mL of DMF was added to the reaction vessel for peptide solid phase synthesis, followed by reaction for 30 minutes. Then washed with 8 mL of DCM (6 times, 20 seconds each). Further, 2 mmol of Boc-Gly-OH was dissolved in 4 mL of DCM, and then subjected to a so-called double coupling method in which the same operation was repeated in an amino acid activation reaction vessel, followed by filtration to obtain a Boc-Gly-MBHA resin.

계속하여, 얻어진 Boc-Gly-MBHA 수지를 DCM 8mL로 세척하고(4회, 각 1분간) 여과하였다. 이것에 60% TFA 함유 DCM 8mL(20분간), DCM 4mL(3회, 각 15초간), DIEA 1mL 함유 DMF 용액 3mL(2회, 각 1분간), DMF 8mL(6회, 각 40초간)의 순으로 아르곤가스 기류속에서 교반하여 처리하고, 또한 각각의 처리마다 여과를 행하였다.Subsequently, the obtained Boc-Gly-MBHA resin was washed with 8 mL of DCM (4 times, 1 minute each) and filtered. It contains 8 mL of DCM (20 minutes) with 60% TFA, 4 mL of DCM (3 times for 15 seconds each), 3 mL of DMF solution containing 1 mL of DIEA (2 times for 1 minute each), and 8 mL of DMF (6 times for 40 seconds each). In order, it processed by stirring in argon gas airflow, and it filtered by each process.

또한, pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2의 아미노산 서열 제 9번째의 아미노산 잔기에 반응하는 Boc-Pro-OH 2mmol을 DCM 4mL에 용해시켜 아미노산 활성화 용기에 넣고, DCC(0.5M-DCM 용액) 1.5mL을 첨가하여 7분간 반응시켰다. 그 후 반응혼합액을 여과하여 농축용기로 옮기고, 이것에 DMF 3mL를 첨가하고, 아르곤가스 기류하에서 DCM을 제거하였다. 여기에 DMF 3mL를 첨가하고 전기의 펩티드 고상합성용 반응용기로 옮겨 30분간 반응시켰다. 계속해서 DCM 8mL로 세척하고(6회, 각 20초간) 여과하여 Boc-Pro-Gly-MBHA 수지를 얻었다.In addition, 2 mmol of Boc-Pro-OH reacting with the ninth amino acid residue of the amino acid sequence of pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH 2 was dissolved in 4 mL of DCM. Into the amino acid activation vessel, 1.5 mL of DCC (0.5M-DCM solution) was added and allowed to react for 7 minutes. Thereafter, the reaction mixture was filtered and transferred to a concentration vessel, and 3 mL of DMF was added thereto, and DCM was removed under an argon gas stream. 3 mL of DMF was added thereto, and the reaction mixture was transferred to a reaction vessel for peptide solid phase synthesis and allowed to react for 30 minutes. Then washed with 8 mL of DCM (6 times, 20 seconds each) and filtered to give Boc-Pro-Gly-MBHA resin.

이하, 표 2에 나타내는 아미노기 보호 아미노산을 이용하여 순차적으로 8번째부터 4번째까지의 아미노산을 커플링하였다.Hereinafter, 8th to 4th amino acids were coupled sequentially using the amino group protection amino acid shown in Table 2.

아미노산 순서Amino acid sequence 보호아미노산Protection amino acid 사용량(mmol)Usage (mmol) 8765487654 Boc-Arg(Tos)-OHBoc-Leu-OHBoc-D-Trp-OHBoc-Tyrr(Bzl)-OHBoc-Ser(Bzl)-OHBoc-Arg (Tos) -OHBoc-Leu-OHBoc-D-Trp-OHBoc-Tyrr (Bzl) -OHBoc-Ser (Bzl) -OH 2×222222 × 22222

상기 고상합성에 있어서, 아르기닌을 이용한 경우는 더블커플링을 행하였다.In the above-mentioned solid phase synthesis, when arginine was used, double coupling was performed.

이렇게 하여 보호펩티드-MBHA 수지, Boc-Ser(Bzl)-Tyr(Bzl)-D-Trp-Leu-Arg(Tos)-Pro-Gly-MBHA 수지 2.76g을 얻었다.Thus, 2.76 g of a protective peptide-MBHA resin and Boc-Ser (Bzl) -Tyr (Bzl) -D-Trp-Leu-Arg (Tos) -Pro-Gly-MBHA resin were obtained.

상기 보호펩티드-MBHA 수지 2.76g에 아니솔 5mL을 첨가하고, 또한 무수 불화수소(HF) 25mL를 첨가하여 0℃에서 1시간 교반하였다. 반응후, 무수 불화수소를 감압하에서 증류하여 제거하고 잔사를 에테르로 세척하였다. 이렇게 하여 H-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH21.30g이 얻어졌다.5 mL of anisole was added to 2.76 g of the protective peptide-MBHA resin, and 25 mL of anhydrous hydrogen fluoride (HF) was added, followed by stirring at 0 ° C for 1 hour. After the reaction, anhydrous hydrogen fluoride was distilled off under reduced pressure and the residue was washed with ether. Thus, 1.30 g of H-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH 2 was obtained.

H-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2의 선광도, TLC의 Rf 및 원소분석값을 하기에 나타내었다.The photosensitivity of H-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH 2 , Rf of TLC and elemental analysis values are shown below.

[α]D: -50.4(c=1.0, MeOH)[α] D : -50.4 (c = 1.0, MeOH)

Rf : 0.13(BuOH/AcOH/H2O=4/1/5)Rf: 0.13 (BuOH / AcOH / H 2 O = 4/1/5)

원소분석값(C59H84N16O12·AcOH·2H2O로서)Elemental analysis value (as C 59 H 84 N 16 O 12 .AcOH.2H 2 O)

이론값 C: 54.31% H: 7.04% N: 17.27%Theoretical C: 54.31% H: 7.04% N: 17.27%

측정값 C: 54.20% H: 6.89% N: 16.97%Found C: 54.20% H: 6.89% N: 16.97%

(5-2) pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2의 제조(5-2) Preparation of pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH 2

H-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt 대신에, 상기(5-1)로 제조한 H-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH21.30g을 이용한 것을 제외하고는, 실시예 1의 (1-11)과 같은 방법에 의하여 pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH21.26g(수율 75.45%)을 얻었다.Instead of H-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-NHEt, H-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly- PGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH 2 1.26 by the same method as (1-11) of Example 1, except that NH 2 1.30 g was used. g (yield 75.45%) was obtained.

pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2의 선광도, TLC의 Rf 및 원소분석값을 하기에 나타내었다.The photoluminescence of pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH 2 , Rf of TLC and elemental analysis values are shown below.

[α]D: -56.6(c=1.0, H2O)[α] D : -56.6 (c = 1.0, H 2 O)

원소분석값(C64H82N18O13·AcOH·2H2O로서)Elemental analysis value (as C 64 H 82 N 18 O 13 · AcOH · 2H 2 O)

이론값 C: 56.32% H: 6.44% N: 17.91%Theoretical C: 56.32% H: 6.44% N: 17.91%

측정값 C: 56.20% H: 6.38% N: 16.97%Found C: 56.20% H: 6.38% N: 16.97%

아미노산 조성Amino acid composition

Ser 0.98(1), Glu 1.07(1), Gly 1.01(1), Pro 0.99(1), Leu 1.00(1), Tyr 0.92(1), His 0.95(1), Arg 1.08(1)Ser 0.98 (1), Glu 1.07 (1), Gly 1.01 (1), Pro 0.99 (1), Leu 1.00 (1), Tyr 0.92 (1), His 0.95 (1), Arg 1.08 (1)

실시예 6: pGlu-His-Trp-Ser-Tyr-(2-나프틸)-D-Ala-Leu-Arg-Pro-Gly-NH2의 제조Example 6: Preparation of pGlu-His-Trp-Ser-Tyr- (2-naphthyl) -D-Ala-Leu-Arg-Pro-Gly-NH 2

(6-1) H-Ser-Tyr-(2-나프틸)-D-Ala-Leu-Arg-Pro-Gly-NH2의 제조(6-1) Preparation of H-Ser-Tyr- (2-naphthyl) -D-Ala-Leu-Arg-Pro-Gly-NH 2

제 6번째 아미노산 잔기에 대응하는 Boc-D-Trp-OH 대신에, Boc-D-(2-나프틸)-D-Ala-OH를 사용한 것을 제외하고는, 실시예 5의 (5-1)과 같은 처리를 하여 H-Ser-Tyr-(2-나프틸)-D-Ala-Leu-Arg-Pro-Gly-NH20.98g을 얻었다.Example 5 (5-1), except that Boc-D- (2-naphthyl) -D-Ala-OH was used instead of Boc-D-Trp-OH corresponding to the sixth amino acid residue 0.98 g of H-Ser-Tyr- (2-naphthyl) -D-Ala-Leu-Arg-Pro-Gly-NH 2 was obtained.

H-Ser-Tyr-(2-나프틸)-D-Ala-Leu-Arg-Pro-Gly-NH2의 선광도, TLC의 Rf 및 원소분석값을 하기에 나타내었다.The photosensitivity of H-Ser-Tyr- (2-naphthyl) -D-Ala-Leu-Arg-Pro-Gly-NH 2 , Rf of TLC and elemental analysis values are shown below.

[α]D: -44.1(c=1.0, MeOH)[α] D : -44.1 (c = 1.0, MeOH)

Rf : 0.15Rf: 0.15

원소분석값(C47H66N12O10로서)Elemental Analysis Values (as C 47 H 66 N 12 O 10 )

이론값 C: 58.86% H: 6.94% N: 17.52%Theoretical C: 58.86% H: 6.94% N: 17.52%

측정값 C: 58.72% H: 6.88% N: 17.49%Found C: 58.72% H: 6.88% N: 17.49%

(6-2) pGlu-His-Trp-Ser-Tyr-(2-나프틸)-D-Ala-Leu-Arg-Pro-Gly-NH2의 제조(6-2) Preparation of pGlu-His-Trp-Ser-Tyr- (2-naphthyl) -D-Ala-Leu-Arg-Pro-Gly-NH 2

H-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt 대신에, 상기(6-1)로 제조한 H-Ser-Tyr-(2-나프틸)-D-Ala-Leu-Arg-Pro-Gly-NH20.98g을 이용한 것을 제외하고는, 실시예 1의 (1-11)과 같은 방법에 의하여 pGlu-His-Trp-Ser-Tyr-(2-나프틸)-D-Ala-Leu-Arg-Pro-Gly-NH20.93g(수율 76.2%)을 얻었다.Instead of H-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-NHEt, H-Ser-Tyr- (2-naphthyl) -D-Ala-Leu produced by (6-1) above PGlu-His-Trp-Ser-Tyr- (2-naphthyl) -D by the same method as (1-11) of Example 1, except that 0.98 g of -Arg-Pro-Gly-NH 2 was used. 0.93 g (76.2% yield) of Ala-Leu-Arg-Pro-Gly-NH 2 was obtained.

pGlu-His-Trp-Ser-Tyr-(2-나프틸)-D-Ala-Leu-Arg-Pro-Gly-NH2의 선광도, 원소분석값 및 아미노산 분석값을 하기에 나타내었다.The photoluminescence, elemental analysis and amino acid analysis of pGlu-His-Trp-Ser-Tyr- (2-naphthyl) -D-Ala-Leu-Arg-Pro-Gly-NH 2 are shown below.

[α]D: -50.3(c=1.0, H2O)[α] D : -50.3 (c = 1.0, H 2 O)

원소분석값(C69H88N18O14로서)Elemental Analysis Values (as C 69 H 88 N 18 O 14 )

이론값 C: 59.47% H: 6.37% N: 18.09%Theoretical C: 59.47% H: 6.37% N: 18.09%

측정값 C: 59.40% H: 6.33% N: 17.98%Found C: 59.40% H: 6.33% N: 17.98%

아미노산 조성Amino acid composition

Ser 0.98(1), Glu 1.05(1), Gly 1.00(1), Pro 1.03(1), Leu 1.00(1), Tyr 0.93(1), His 0.94(1), Arg 1.07(1)Ser 0.98 (1), Glu 1.05 (1), Gly 1.00 (1), Pro 1.03 (1), Leu 1.00 (1), Tyr 0.93 (1), His 0.94 (1), Arg 1.07 (1)

실시예 7: pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2(서열번호 1)의 제조Example 7: Preparation of pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH 2 (SEQ ID NO: 1)

(7-1) H-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2(서열번호 4)의 제조(7-1) Preparation of H-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH 2 (SEQ ID NO: 4)

제 6번째 아미노산 잔기에 대응하는 Boc-D-Trp-OH 대신에, Boc-Gly-OH를 이용한 것을 제외하고는, 실시예 5의 (5-1)과 같은 처리를 하여 H-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2(서열번호 4) 1.12g을 얻었다.Instead of Boc-D-Trp-OH corresponding to the sixth amino acid residue, H-Ser-Tyr- was subjected to the same treatment as in Example 5 (5-1) except that Boc-Gly-OH was used. 1.12 g of Gly-Leu-Arg-Pro-Gly-NH 2 (SEQ ID NO: 4) was obtained.

H-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2의 선광도, TLC의 Rf 및 원소분석값을 하기에 나타내었다.The photoluminescence of H-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH 2 , Rf of TLC and elemental analysis values are shown below.

[α]D: -40.1(c=1.0, MeOH)[α] D : -40.1 (c = 1.0, MeOH)

Rf : 0.10(BuOH/AcOH/H2O=4/1/5)Rf: 0.10 (BuOH / AcOH / H 2 O = 4/1/5)

원소분석값(C33H53N11O9로서)Elemental Analysis Values (as C 33 H 53 N 11 O 9 )

이론값 C: 53.00% H: 7.14% N: 20.60%Theoretical C: 53.00% H: 7.14% N: 20.60%

측정값 C: 53.20% H: 6.89% N: 20.97%Found C: 53.20% H: 6.89% N: 20.97%

(7-2) pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2(서열번호 1)의 제조(7-2) Preparation of pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH 2 (SEQ ID NO: 1)

H-Ser-Tyr-D-Ser(But)-Leu-Arg-Pro-NHEt 대신에, 상기(6-1)로 제조한 H-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2(서열번호 4) 1.12g을 이용한 것을 제외하고는, 실시예 1의 (1-11)과 같은 방법에 의하여 pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2(서열번호 1) 1.16g(수율 76.3%)을 얻었다.Instead of H-Ser-Tyr-D-Ser (But) -Leu-Arg-Pro-NHEt, H-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH 2 produced by (6-1) above (SEQ ID NO: 4) pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH 2 by the same method as (1-11) of Example 1, except that 1.12 g was used. (SEQ ID NO: 1) 1.16 g (yield 76.3%) were obtained.

pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2의 원소분석값 및 아미노산 분석값을 하기에 나타내었다.Elemental analysis and amino acid analysis of pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH 2 are shown below.

원소분석값(C55H75N17O13·AcOH·2H2O로서)Elemental analysis value (C 55 H 75 N 17 O 13 · AcOH · 2H 2 O a)

이론값 C: 53.55% H: 6.54% N: 18.63%Theoretical C: 53.55% H: 6.54% N: 18.63%

측정값 C: 53.85% H: 6.89% N: 18.97%Found C: 53.85% H: 6.89% N: 18.97%

아미노산 조성Amino acid composition

Ser 1.01(1), Glu 1.03(1), Gly 2.01(2), Pro 0.98(1), Leu 1.01(1), Tyr 0.94(1), His 0.94(1), Arg 1.08(1)Ser 1.01 (1), Glu 1.03 (1), Gly 2.01 (2), Pro 0.98 (1), Leu 1.01 (1), Tyr 0.94 (1), His 0.94 (1), Arg 1.08 (1)

본 발명의 방법은 효소반응을 이용하기 때문에, 라세미화 등의 부반응을 수반하지 않으므로 LH-RH 유도체의 분리, 정제가 용이하다. 또한, 수율이 높고 미반응의 펩티드 단편을 회수하여 재이용 가능하므로 공업적으로 매우 유용하다.Since the method of the present invention uses an enzymatic reaction, it does not involve side reactions such as racemization and the like, so that the LH-RH derivative can be easily separated and purified. In addition, since the yield is high and unreacted peptide fragments can be recovered and reused, they are very useful industrially.

Claims (7)

하기 일반식(1)로 표시되는 펩티드 단편과, 하기 일반식(2)로 표시되는 펩티드 단편을 키모트립신 또는 키모트립신 유사 효소로 이루어지는 군에서 선택된 효소의 존재하에서 반응시키는 것을 특징으로 하는 하기 일반식(3)으로 표시되는 LH-RH 유도체의 제조방법:The peptide fragment represented by the following general formula (1) and the peptide fragment represented by the following general formula (2) are reacted in the presence of an enzyme selected from the group consisting of chymotrypsin or chymotrypsin-like enzyme. Process for preparing LH-RH derivative represented by (3): pGlu-His-Trp-OR1(1)pGlu-His-Trp-OR 1 (1) H-Ser-Tyr-X-Leu-Arg-Pro-Y (2)H-Ser-Tyr-X-Leu-Arg-Pro-Y (2) pGlu-His-Trp-Ser-Tyr-X-Leu-Arg-Pro-Y (3)pGlu-His-Trp-Ser-Tyr-X-Leu-Arg-Pro-Y (3) 상기 식에서,Where R1은 저급 알킬을 나타내고,R 1 represents lower alkyl, X는 D-Leu, D-Ser(But), D-Trp, (2-나프틸)-D-Ala, Leu 및 Gly로 이루어진 군에서 선택된 아미노산을 나타내고,X represents an amino acid selected from the group consisting of D-Leu, D-Ser (But), D-Trp, (2-naphthyl) -D-Ala, Leu and Gly, Y는 Gly-NH2, Azgly(아자글리신)-NH2또는 NHR2(R2는 저급 알킬이다)을 나타낸다.Y represents Gly-NH 2 , Azgly (azaglycine) -NH 2 or NHR 2 (R 2 is lower alkyl). 제 1항에 있어서,The method of claim 1, 전기 R1이 탄소수가 1 내지 3 알킬기인 것을 특징으로 하는 LH-RH 유도체의 제조방법.Method for producing a LH-RH derivative, characterized in that the electric R 1 is a C1-3 alkyl group. 제 1항 또는 제 2항에 있어서,The method according to claim 1 or 2, 전기 R2가 탄소수가 1 내지 3 알킬기인 것을 특징으로 하는 LH-RH 유도체의 제조방법.Method for producing a LH-RH derivative, characterized in that the electricity R 2 is an alkyl group having 1 to 3 carbon atoms. 제 1항 내지 3항의 어느 한 항에 있어서,The method according to any one of claims 1 to 3, 전기 키모트립신 또는 키모트립신 유사 효소로 이루어지는 군에서 선택되는 효소가 키모트립신인 것을 특징으로 하는 LH-RH 유도체의 제조방법.A method for producing an LH-RH derivative, wherein the enzyme selected from the group consisting of the aforementioned chymotrypsin or chymotrypsin-like enzyme is chymotrypsin. 하기 일반식(4)로 표시되는 펩티드 단편과, 하기 일반식(5)로 표시되는 펩티드 단편을 키모트립신 또는 키모트립신 유사 효소로 이루어지는 군에서 선택되는 효소의 존재하에서 물 또는 완충용액과 유기용매를 혼합한 용매속에서 반응시키는 것을 특징으로 하는 하기 일반식(6)으로 표시되는 LH-RH 유도체의 제조방법:The peptide fragment represented by the following general formula (4) and the peptide fragment represented by the following general formula (5) include water or a buffer solution and an organic solvent in the presence of an enzyme selected from the group consisting of chymotrypsin or chymotrypsin-like enzyme. Process for preparing LH-RH derivative represented by the following general formula (6), characterized in that the reaction in a mixed solvent: pGlu-His-Trp-OR1(4)pGlu-His-Trp-OR 1 (4) H-Ser-Tyr-X-Leu-Arg-Pro-Y (5)H-Ser-Tyr-X-Leu-Arg-Pro-Y (5) pGlu-His-Trp-Ser-Tyr-X-Leu-Arg-Pro-Y (6)pGlu-His-Trp-Ser-Tyr-X-Leu-Arg-Pro-Y (6) 상기 식에서,Where R1은 저급 알킬을 나타내고,R 1 represents lower alkyl, X는 D-Leu, D-Ser(But), D-Trp, (2-나프틸)-D-Ala 및 Gly로 이루어지는 군에서 선택되는 아미노산을 나타내며,X represents an amino acid selected from the group consisting of D-Leu, D-Ser (But), D-Trp, (2-naphthyl) -D-Ala and Gly, Y는 Gly-NH2, Azgly-NH2또는 NHR2(R2는 저급 알킬이다)를 나타낸다.Y represents Gly-NH 2 , Azgly-NH 2 or NHR 2 (R 2 is lower alkyl). 제 5항에 있어서,The method of claim 5, 전기 물 또는 완충용액과 유기용매를 혼합한 용매가 물 또는 완충용액과 수혼화성 유기용매와의 혼합용매, 또는 물이나 완충용액을 물과 부분적으로 혼화하는 유기용매로 포화시킨 혼합용매인 것을 특징으로 하는 LH-RH 유도체의 제조방법.The solvent in which the electric water or the buffer solution and the organic solvent are mixed is water or a mixed solvent of the buffer solution with the water-miscible organic solvent, or a mixed solvent saturated with an organic solvent which partially mixes the water or the buffer solution with water. Method for producing a LH-RH derivative. 하기 일반식(7)로 표시되는 펩티드 단편과, 하기 일반식(8)로 표시되는 펩티드 단편을 키모트립신 또는 키모트립신 유사 효소로 이루어지는 군에서 선택되는 효소를 고정화한 고정화 효소의 존재하에서, 물 또는 완충용액과 유기용매를 혼합한 용매에서 반응시키는 것을 특징으로 하는 일반식(9)로 표시되는 LH-RH 유도체의 제조방법:In the presence of an immobilized enzyme wherein the peptide fragment represented by the following general formula (7) and the peptide fragment represented by the following general formula (8) are immobilized with an enzyme selected from the group consisting of chymotrypsin or chymotrypsin-like enzyme, A method for preparing an LH-RH derivative represented by Formula (9), which is characterized by reacting a buffer solution with an organic solvent in a mixed solvent: pGlu-His-Trp-OR1(7)pGlu-His-Trp-OR 1 (7) H-Ser-Tyr-X-Leu-Arg-Pro-Y (8)H-Ser-Tyr-X-Leu-Arg-Pro-Y (8) pGlu-His-Trp-Ser-Tyr-X-Leu-Arg-Pro-Y (9)pGlu-His-Trp-Ser-Tyr-X-Leu-Arg-Pro-Y (9) 상기 식에서,Where R1은 저급 알킬을 나타내고,R 1 represents lower alkyl, X는 D-Leu, D-Ser(But), D-Trp, (2-나프틸)-D-Ala 및 글라이신으로 이루어지는 군에서 선택되는 아미노산을 나타내며,X represents an amino acid selected from the group consisting of D-Leu, D-Ser (But), D-Trp, (2-naphthyl) -D-Ala and glycine, Y는 Gly-NH2, Azgly-NH2또는 NHR2(R2는 저급 알킬이다)을 나타낸다.Y represents Gly-NH 2 , Azgly-NH 2 or NHR 2 (R 2 is lower alkyl).
KR1020007001226A 1997-08-04 1997-08-04 Process for Producing LH-RH Derivatives KR20010022632A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1997/002705 WO1999007874A1 (en) 1996-06-13 1997-08-04 Process for producing lh-rh derivatives

Publications (1)

Publication Number Publication Date
KR20010022632A true KR20010022632A (en) 2001-03-26

Family

ID=14180932

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020007001226A KR20010022632A (en) 1997-08-04 1997-08-04 Process for Producing LH-RH Derivatives

Country Status (3)

Country Link
KR (1) KR20010022632A (en)
AU (1) AU3708697A (en)
CA (1) CA2299267A1 (en)

Also Published As

Publication number Publication date
CA2299267A1 (en) 1999-02-18
AU3708697A (en) 1999-03-01

Similar Documents

Publication Publication Date Title
CA2052375C (en) Parathyroid hormone derivatives
EP0561412B1 (en) Parathyroid hormone derivatives
FUJII et al. Studies on peptides. CLV. Evaluation of trimethylsilyl bromide as a hard-acid deprotecting reagent in peptide synthesis
US5602231A (en) Process for making peptides
JP5908478B2 (en) h “Gly2” GLP-2 Solid Phase Synthesis
EP1179537B1 (en) Solid phase peptide synthesis method
Breddam et al. Amidation of growth hormone releasing factor (1–29) by serine carboxypeptidase catalysed transpeptidation
US4473555A (en) Nona- and dodecapeptides for augmenting natural killer cell activity
EP0518656B1 (en) Solid phase peptide synthesis
Izeboud et al. Synthesis of substance P via its sulfoxide by the repetitive excess mixed anhydride (REMA) method
WAKIMASU et al. 4-Methoxy-2, 3, 6-trimethylbenzenesulfonyl (Mtr): a new amino and imidazole protecting group in peptide synthesis
US6448031B1 (en) Process for producing LH-RH derivatives
CZ1021084A3 (en) Gonadoliberin derivatives and process for preparing thereof
SAKAMOTO et al. Chemical synthesis of phosphorylated peptides of the carboxy‐terminal domain of human p53 by a segment condensation method
US5059679A (en) Method of selectively sulfating peptides
KR20010022632A (en) Process for Producing LH-RH Derivatives
Borin et al. Synthetic and binding studies on the calcium binding site I of bovine brain calmodulin: II. Synthesis and CD studies on the cyclic 20–31 sequence
JP3249915B2 (en) Method for producing LH-RH derivative
JP2777193B2 (en) Method for producing peptide
US5432263A (en) Process for producing peptides with side chains containing imidazolinylamino, tetrahydropyrimidinylamino, or alkylguanidinyl groups
YAMASHIRO et al. Synthesis and properties of human β‐endorphin‐(1–9) and its analogs
EP0056274A1 (en) Indole derivatives and a method for production of peptides
JPWO2007043615A1 (en) Peptide ester reagents and their use for the production of ligation or thioester compounds
RU2073010C1 (en) Method of synthesis of lysine-vasopressin in solution
FEHRENTZ et al. Solution synthesis of antigenic and inhibiting peptides of the human renin prosegment‐1: [Tyr 47, Nle 53] preprorenin‐(47–60) peptide methyl ester

Legal Events

Date Code Title Description
WITN Withdrawal due to no request for examination